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ABSTRACT 
 
The Effects of Tau Proteins on Microtubule Mechanics and Molecular Motor Transport 
 
by 
 
Dezhi Yu 
 
Microtubules are an essential component of the cytoskeleton that provide structural integrity 
and facilitate important functions in cells. In this work, I will explore several aspects of 
microtubule mechanics and function using a wide range of biophysical techniques. I am 
particularly interested in the effects of stabilizing agents, including small molecule inhibitors 
of microtubule dynamics (such as taxol or epothilone), and microtubule-binding proteins, 
such as tau. First, using advanced spectral analytical techniques, we studied the effects of tau 
proteins on the mechanical properties of single microtubule (MT) filaments under controlled 
in vitro conditions. We found that the short forms of 3-repeat (3R) and 4-repeat (4R) wild-
type (WT) tau proteins reduce the stiffness of taxol-assembled MTs compared to a no tau 
control, despite the fact that the microtubule diameter is known to increase when these tau 
proteins bind. In contrast, single point tau mutants P301L, R406W and ΔN296, which are all 
linked to devastating neurological diseases, do not have significant effects on microtubule 
stiffness compared to a no tau control, raising interesting questions about possible 
mechanical origins of tauopathy diseases. 
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Next, we examined the effects of tau proteins on in vitro transport properties of kinesin-
bound cargoes on microtubules. In comparison to the no tau control, kinesin-bound quantum 
dot cargoes had lower velocity and shorter run lengths in the presence of tau when moving on 
taxol-assembled microtubules. Most of the single point tau mutants that we tested showed 
similar slowing of cargo translocation, with speed reductions similar to those observed with 
WT tau. One exception was the 4R short R406W mutant tau, in which the velocities of 
kinesin-bound cargoes were significantly lower than in WT case.  The disease mechanism for 
mutant has been particularly puzzling, so our results may suggest a more prominent role in 
disruption of axonal transport than was previously appreciated. 
 
Next, we investigated the effects of microtubule-stabilizing chemicals epothilone-A and -B 
on 1) microtubule mechanics, 2) the transport properties of kinesins and 3) the ability of WT 
tau proteins modify the stiffness of microtubules assembled with epothilone. We found that 
microtubules assembled in the presence of epothilone-A or –B were less stiff compared to 
taxol-assembled MTs, and the addition of WT tau further reduced the stiffness. However, the 
differences in stiffness/persistence length between epothilone-assembled microtubules and 
taxol-assembled microtubules diminished after the addition of WT tau. Kinesin translocation 
speed was sensitive to the type of stabilizing chemical, and the changes in velocity in the 
presence of tau were also depended on the assembly condition. Epothiolone and taxol 
compunds are both frequently used in cancer chemotherapies, and our results shed light on 
the possible molecular mechanisms of neurological side effects (such as debilitating nerve 
pain) when these agents are used. 
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Lastly, we looked at the effects of tau on intracellular trafficking in COS-7 cells. We found 
that the microtubule network in the cells were dramatically modified after the introduction of 
tau via transient transfection, with substantial bundling, aggregation and membrane-
association in the presence of tau. However, there were no obvious differences in the 
microtubule network structures between cells that were transfected with mutant tau and wild-
type tau. Interestingly, despite the major modification of the cytoskeletal structures in the 
presence of tau, the measured velocities of lysosomes in directed transport in cells that were 
transfected with tau were not significantly different compared to the lysosome velocities in 
cells with no tau. 
 
Taken together, studies provide important new insights into how tau proteins and other small 
molecule stabilizers modulate the mechanical and functional properties of cytoskeletal 
microtubules and how misregulations in tau may be related to the development of 
neurodegeneration and dementia diseases. 
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I. Introduction 
The cytoskeleton is comprised of several interpenetrated biopolymer networks inside a cell 
that composed with three classes of filaments: actin, intermediate filaments and 
microtubules.  The cytoskeletal network not only provides structural support to maintain the 
integrity of a cell, it also participates in and facilitates in many essential processes such as 
force generation, cell division and intracellular transport. Microtubules (MTs) are the stiffest 
of the cytoskeletal polymers and are well known for their role in facilitating axonal transport 
in mammalian neurons. These unique properties and physiological relevance make MTs one 
of the most interesting topics to study in both the field of polymer science and biology.   
 
Microtubules are polymers formed from α- and β- tubulin dimers (Figure 1-1). In cells, these 
tubulin dimers self-assemble into microscopic tubes with 13 protofilaments, outer diameter 
of ~25 nm and inner diameter of ~15 nm. MTs are structurally-asymmetry (or "polar") 
polymers with tubulin additions mainly occurring in the fast-growing + ends of the polymers 
where the β- tubulins were exposed. MTs generally grow from the centers to the peripheries 
of the cells. Unlike conventional synthetic polymers, tubulin dimers in MTs are not 
covalently bonded and MTs inside cells undergo periods of growth and shrinkage in a 
process as known as dynamic instability [1]. The dynamics of MTs in cells are regulated by 
different microtubule associated proteins (MAPs).  MT binding protein, tau, is one of the 
best-studied MAPs that will be investigated extensively in my research and will be described 
in more detail in latter parts of this proposal. Other than through the use of MAPs, MT 
dynamics can also be regulated using synthetic chemicals. Paclitaxol (taxol) is a small-
molecule inhibitor known to stabilize MTs and inhibit MT dynamic instability [2], and it is 
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used in chemotherapy to treat solid-mass cancers. These MAPs and small molecule stabilizer 
are also known to change MT structure by modulating the number of tubulin protofilaments 
and to modify the molecular structure and conformation of tubulin dimers [3-6]. These 
changes in MT structure not only affect the material and mechanical properties of MTs, but 
also change the geometry of the MT surface and possibly create physical hindrances, which 
can alter the binding and stepping behaviors of molecular motors [7]. Disruptions, 
misregulations and blockages in motor-driven transport can be detrimental to the well-being 
of cells, especially neurons where directed molecular transport along long axons are 
prominent and essential to cell health [8].      
 
 
Figure 1-1: Schematic picture of microtubule structure 
 
 
This thesis will discuss the following topics: 1) Exploring the mechanical properties of MTs 
in vitro under various chemical conditions (i.e. in the presence/absence of different 
microtubule associated proteins, different types of chemical stabilizers, and/or different types 
of nucleotides) in efforts to understand and establish models of how the structures of MTs 
vary under different conditions. 2) Investigating the effects of tau and disease-related 
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mutations of tau proteins on MT functional properties such as intracellular transport, which is 
investigated using kinesin translocation on MTs under simplified in vitro systems, in order to 
understand the role of intracellular transport or the lack thereof in disease and dementia 
development. 3) Applying similar biophysical tools to study the effect of wild-type and 
mutant tau on cargo trafficking in a highly complex system inside a cell.   
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II. Tau Proteins Harboring Neurodegeneration-linked Mutations 
Impair Kinesin Translocation in vitro1 
The following work was a collaborated project between the Valentine Lab, Mechanical 
Engineering, UCSB, the Feinstein Lab, MCDB, UCSB and the Wilson Lab, MCDB, UCSB. 
All information in this section was published in the Journal of Alzheimer’s Disease in 2014 
[9]. All supplemental materials can be found on publisher’s website site.   
 
In this section, we will investigate the effect of wild-type tau and disease-related tau mutants 
on in vitro transport properties of kinesins.  
 
A. Abstract 
We tested the hypothesis that mutant tau proteins that cause neurodegeneration and dementia 
differentially alter kinesin translocation along MTs relative to normal tau in vitro. We 
employed complementary in vitro motility assays using purified recombinant kinesin, 
purified recombinant tau and purified bovine brain α:β tubulin to isolate interactions among 
these components without any contribution by cellular regulatory mechanisms. We found 
that kinesin translocates slower along MTs assembled by any of three independent tau 
mutants (4-repeat P301L tau, 4-repeat ΔN296 tau and 4-repeat R406W tau) relative to its 
translocation rate along MTs assembled by normal, 4-repeat wild type (WT) tau. Moreover, 
the R406W mutation exhibited isoform specific effects; while kinesin translocation along 4-
repeat R406W tau assembled MTs is slower than along MTs assembled by 4-repeat WT tau, 
                                                 
1 Reprinted from Journal of Alzheimer's Disease 39 (2), Yu, D., et al., Tau Proteins Harboring 
Neurodegeneration-Linked Mutations Impair Kinesin Translocation in vitro, 301-314, Copyright (2014), with 
permission from IOS Press. 
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the R406W mutation had no effect in the 3-repeat tau context. These data provide strong 
support for the notion that aberrant modulation of kinesin translocation is a component of 
tau-mediated neuronal cell death and dementia. Finally, we showed that assembling MTs 
with taxol before coating them with mutant tau obscured effects of the mutant tau that were 
readily apparent using more physiologically relevant MTs assembled with tau alone, raising 
important issues regarding the use of taxol as an experimental reagent and novel insights into 
therapeutic mechanisms of taxol action.  
 
B. Introduction 
The amyloid hypothesis, built upon both genetic and biochemical observations, suggests that 
Alzheimer’s disease (AD) is initiated by the Aβ peptide, a small fragment derived from the 
amyloid precursor protein. More recent investigations indicate that Aβ-mediated neuronal 
cell death requires downstream action by tau [10], a neural microtubule (MT)-associated 
protein (MAP) that is essential for the normal development and maintenance of the central 
nervous system (CNS) [11-13]. Biochemically, AD tau is known to be hyperphosphorylated, 
fragmented and assembled into aggregates known as neurofibrillary tangles. These same tau 
modifications are also observed in numerous AD-related neurodegenerative diseases, 
collectively known as tauopathies [14, 15]. 
 
A number of tauopathies, including FTDP-17, PSP and CBD, have been genetically linked to 
mutations in the tau gene [10, 16-20]. Patients with these diseases do not exhibit any Aβ 
abnormalities, consistent with a downstream role for tau in Aβ-mediated neuronal cell death 
in AD and demonstrating that aberrant tau action alone is sufficient to cause 
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neurodegeneration. Disease-linked tau mutations fall into two groups: structural mutations 
that alter the tau amino acid sequence, and regulatory mutations that alter the expression 
ratios of the six different CNS tau isoforms generated via developmentally controlled 
alternative RNA splicing (Figure 2-1) [21-23]. The mechanisms by which these tau 
mutations promote neurodegeneration and dementia remain poorly understood, but once 
elucidated, may provide insights into the pathogenesis of AD and other tauopathies.  
 
It has been recently hypothesized that errors in cargo transport along MTs may underlie some 
aspects of neurodegeneration in AD and other diseases (for example, see [24-26]), leading to 
increasing efforts to examine the role of tau in axonal transport. A number of cellular studies 
have shown that wild type (WT) tau can regulate kinesin activity and that the disruption of 
tau-kinesin interactions can compromise axonal transport. For example, over-expression of 
WT tau in cultured neuronal cells led to impaired axonal transport, organelle depletion in 
neuronal processes, enhanced oxidative stress in distal neuritic regions and a net retrograde 
bias of dynein-associated cargo [8, 27-29]. Similarly, over-expression of WT tau in 
transgenic mice led to axonal degeneration and accumulation of mitochondria and vesicles in 
the cell soma [30]. However, the magnitude of tau-mediated effects upon kinesin was less 
marked in other experimental systems. For example, tau showed a limited effect on axonal 
transport in murine retinal ganglion cells [31] and isolated squid axoplasm [32].  
 
In vitro studies using completely reconstituted systems can identify direct effects of tau on 
kinesin-driven transport along MTs in the absence of complicating cellular regulatory 
mechanisms (such as tau phosphorylation). For example, a number of studies have shown 
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that the addition of WT tau to taxol-assembled MTs in vitro inhibits the subsequent binding 
of kinesin to MTs and decreases the kinesin run length, but has little effect on translocation 
velocity [7, 28, 33, 34]. Importantly, these effects can depend on which alternatively spliced 
isoform of tau is used. Each of the six naturally-occurring tau isoforms possess either three or 
four imperfect repeats in the C-terminal half of the protein (“3R tau” versus “4R tau”), 
separated from one another by shorter inter-repeats (Figure 2-1) [21, 35]. This region of 
repeats and inter-repeats possesses inherent MT binding, MT assembly and MT dynamics 
regulatory activities [36-40]. Each tau isoform also possesses either zero, one or two 
alternatively spliced exons in the N-terminal region of the protein that encodes the 
“projection domain” that is believed to extend outward from the MT surface ([21, 23, 38, 
41]; (see Figure 2-1). Tau isoforms are designated as S (short), M (medium) or L (long), 
when they possess zero, one, or two projection domain insertions, respectively. Surprisingly, 
the shortest isoform of tau (3RS tau) showed a much stronger disruption to kinesin action in 
vitro than the longest tau isoform (4RL tau), suggesting that the decrease in kinesin binding 
affinity and run length was not simply due to physical interference with the fourth MT 
binding repeat or the projection domains, but had a different structural origin [7, 34].  
 
One important but often overlooked possibility is that tau acts indirectly on axonal transport 
by modulating MT structure and topology in a manner that affects the ability of kinesin 
motors to move. Although most biochemical and biophysical assays view MTs as static, inert 
structures upon which MAPs and motor proteins bind, there is increasing evidence that MT 
structure is itself dynamic, regulatable, and sensitive to the presence of MAPs, motor proteins 
and small molecule regulators. For example, both tau and the anti-cancer agent taxol alter 
8 
 
MT protofilament number [6, 42], and both regulate MT dynamics at very low tau:tubulin or 
taxol:tubulin molar ratios [43, 44]. This suggests that small numbers of bound tau or taxol 
molecules might stabilize MTs by inducing long range structural alterations in the MT lattice. 
Long-range interactions have also been suggested to explain how the binding of one kinesin 
dimer to a MT can promote the directionally biased and cooperative binding of additional 
motors [45]. Finally, ultrastructural studies have shown that taxol increases the longitudinal 
intradimer and lateral interdimer bond energies [46], while kinesin binding to α-tubulin 
increases inter-tubulin dimer contact and axial stability along protofilaments [47].  
 
The sensitivity of MT structure and topology to MAPs and small molecules suggests that 
there may not be one uniquely stable MT structure, but rather an ensemble of possible 
structures depending upon the presence of protein and small molecule effectors in solution 
during and after MT assembly. This is supported by a number of measurements of the 
mechanical properties of MTs that show that MT stiffness varies considerably under different 
stabilization conditions [48]. Moreover, these structural and mechanical differences can have 
functional consequences, as shown by recent work demonstrating that tau loses its ability to 
regulate kinesin run length on MTs stabilized by GMPCPP [49]. As further evidence for a 
possible role of MT structure in regulating axonal transport, we recently demonstrated that 
WT tau modulates kinesin-MT interactions in a 3RS tau versus 4RS tau isoform specific 
manner [50]. Importantly, we found the kinesin-MT interactions to be independent of tau 
concentration, ruling out simple steric hindrance mechanisms. Instead, we proposed that MTs 
assembled by 3RS tau and 4RS tau possess qualitatively different structures that support 
different kinesin translocation rates. Taken together, these data suggest that MTs may 
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undergo large length-scale conformational changes in response to various effectors and it is 
therefore reasonable to suggest that a misregulated MT structure could significantly impact 
axonal transport.  
 
In this paper, we extend these arguments exploring the role of tau dysfunction in the context 
of neurodegenerative disease by hypothesizing that mutations in the primary sequence of tau 
contribute to neuronal dysfunction by assembling/stabilizing MTs with aberrant topology that 
support altered kinesin-dependent axonal transport. Using a suite of in vitro motility assays, 
we have identified three independent tau mutations (4R P301L, 4R ΔN296, and 4R R406W) 
that significantly reduce kinesin translocation velocity along MTs relative to WT tau. It is 
important to emphasize that these effects have been detected in a completely defined, 
reconstituted in vitro system, so the effects must be mediated solely by tau, tubulin and 
kinesin without any contribution from phosphorylation or other cell signaling pathways. We 
also find that the presence of taxol can, in many cases, suppress or abolish these mutant tau 
induced effects. These data provide strong support for the hypothesis that the 4R P301L, 4R 
ΔN296, and 4R R406W tau mutants contribute to neurodegenerative/dementia diseases by 
compromising axonal transport, and suggest a possible therapeutic role for taxane-like 
compounds in treating such diseases.  
 
C. Materials and Methods 
1. Purification and Rhodamine Labeling of Tubulin  
MAP-free tubulin dimers (>99% pure) were purified from bovine brain in the absence of any 
stabilizing agents as previously described [51]. Briefly, bovine brain tubulin was purified 
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from brain homogenates by two cycles of polymerization and depolymerization, followed by 
elution through a phosphocellulose column. Rhodamine-labeled tubulin (0.14 mole 
rhodamine per mole tubulin) was prepared by carboxyrhodamine labeling (Molecular Probes) 
as described [52]. 
 
2. Generation and Purification of Recombinant Tau Proteins 
Recombinant tau was produced using pRK expression vectors containing cDNA sequences 
encoding 3RS or 4RS human tau (containing no N-terminal inserts). Site-directed 
mutagenesis was used to generate all tau mutants used in this study from their corresponding 
wild type constructs using a Stratagene QuikChange kit. All mutations were verified by DNA 
sequence analysis (Iowa State DNA Sequencing Facility). In all cases, recombinant tau was 
isolated and purified essentially as previously described [53] except that the final purification 
steps consisted of a HiTrap Phenyl HP column (GE Healthcare) followed by dialysis into 
BRB-80 buffer (80mM PIPES, 1 mM EGTA, 1 mM MgSO4, pH 6.8) supplemented with 
0.1% β-mercaptoethanol. The concentration of purified tau was determined by quantitative 
SDS-PAGE comparison with a tau mass standard [43]. 
 
3. Kinesin Expression and Purification 
The kinesin construct (K560-CL-his) was a gift from Dr. Ron Vale (UCSF). In a pET 
expression vector, the cDNA encodes the N-terminal 560 amino acids of human conventional 
kinesin heavy-chain lacking solvent exposed cysteines but retaining normal enzymatic and 
motile properties [54]. A single point mutation (T560C) at the C-terminus allows for specific 
labeling via maleamide-thiol coupling. The C-terminus of this “cys-lite” (CL) construct also 
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has a hexa-histadine cluster for Ni-affinity purification. K560-CL-his was expressed in BL21 
(DE3) cells (Invitrogen), then cells were lysed and kinesin purified as previously 
described [50].  
 
When prepared for use with quantum dots, the purified kinesin was subsequently labeled 
with EZ-Link® Maleimide-PEG2-Biotin (Thermo Scientific). When prepared for use in 
gliding assays, kinesin was typically further purified by a single ‘bind and release’ cycle 
using established MT-affinity cosedimentation procedures [55]. In both cases, kinesin was 
concentrated, supplemented with 10% sucrose and 0.1 mM ATP, drop frozen in liquid 
nitrogen in single-use aliquots and stored at -80°C.  
 
4. Tau-MT Cosedimentation Assays 
Tau-assembled MTs were prepared by mixing MAP-free tubulin at 15 µM with WT or 
mutant tau at concentrations of 3 µM (1:5 tau to tubulin molar ratio) or 0.5 µM (1:30 tau to 
tubulin molar ratio) in BRB-80 buffer supplemented with 2 mM GTP. Taxol-assembled MTs 
were prepared by mixing MAP-free tubulin with taxol (20 µM final taxol concentration; 
Sigma). Taxol MTs were assembled for 35 min at 35°C, at which time tau was added at 3 
µM or 0.5 µM. After a total of 1 h assembly at 35°C, MTs were layered over 180 µL of a 
35°C sucrose cushion (50% w/v in BRB-80, 2mM GTP) in a 5×20 mm UltraClear centrifuge 
tube (Beckman Coulter).  Samples were centrifuged in a Beckman TLA 100.3 fixed angle 
rotor for 12 min at 60,000 rpm (194,000×g) at 35°C. Supernatants and pellets were collected 
and solubilized in SDS-PAGE sample buffer. The quantities of tau and tubulin in each 
fraction were determined by Western blotting using the monoclonal antibody Tau-1 
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(Millipore) and Coomassie blue staining respectively, taking care to operate within the linear 
detection range. Negligible quantities of tau or tubulin remained within the cushion. These 
data were used to determine the molar ratio of tubulin to tau in the MT pellet. Statistical 
analysis of cosedimentation data was conducted using GraphPad Prism Software. Within 
each assembly condition (1:5 or 1:30 tau:tubulin starting ratio, +/- taxol), data were 
compared using a one-way ANOVA followed by Tukey’s post test. The data reported show 
the significance of comparisons between mutants and their corresponding WT. 
 
5. Kinesin-Driven MT Gliding Assays 
Gliding assays were performed as previously described, with minor modifications [50]. 
Flow-chambers were constructed using ethanol-cleaned glass coverslips and attached to a 
glass slide with double-sided tape. Kinesin was diluted to 20–50 µg/ml in BRB-80 buffer 
containing 10 mM β-mercaptoethanol then flowed into the chamber and allowed to directly 
adhere to the glass surface for ~3–5 min. Following attachment of motors, the chamber was 
blocked for an additional 5 mins with a solution of casein to reduce the non-specific binding 
of MTs to the glass surfaces.  
 
To prepare fluorescent MTs for visualization, rhodamine-tubulin was mixed with unlabeled 
tubulin on ice at a molar ratio of one labeled tubulin dimer to every 3–5 unlabeled tubulin 
dimers, and then one of two polymerization methods was used. To generate taxol-assembled 
MTs, the tubulin mixture was incubated for 5-10 min in a water bath at 35°C. Taxol was then 
introduced in 3 steps, to a concentration of 1 µM, then 6.5 µM, then 20 µM (final) to prevent 
formation of non-MT structures [56]. After each addition, the suspension was incubated for 
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5-10 min at 35 °C. For measurements of taxol-assembled, tau-coated MTs, the appropriate 
tau protein was then added to a final ratio of 1:5 tau to tubulin, and the MTs incubated at 
35ºC for another 15 min. The final tubulin concentration was 20 µM. MTs were then diluted 
1:100 in warm motility buffer containing BRB-80, 5 mM ATP, 0.1% β-mercaptoethanol and 
an enzymatic oxygen scavenger system consisting of glucose oxidase, catalase, and glucose. 
MTs were flowed into the kinesin-containing flow chamber, which was immediately sealed 
with vacuum grease. As a control, taxol-assembled MTs were tested in the absence of tau at 
the beginning and end of each experimental session.  
 
To generate tau-assembled MTs, fluorescent and unlabeled tubulin proteins were mixed with 
tau at a molar ratio of 1:5 tau to tubulin in BRB-80 buffer supplemented with 2 mM GTP. 
MTs were assembled for 1.5 hr at 35ºC then diluted in warm motility buffer containing BRB-
80, 5 mM ATP, an enzymatic oxygen scavenging system (glucose oxidase (Sigma), catalase 
(Sigma), and glucose) and 8% glycerol, which helped to stabilize the MTs against 
depolymerization during data acquisition. The kinesin-containing flow chamber was pre-
warmed to 35ºC on a heat block for ~1 min before MT addition and immediately sealed with 
paraffin wax. Dilution factors were optimized daily to obtain 5–30 MTs per field of view. As 
a control, WT tau-assembled MTs were prepared daily and tracked in parallel with 
corresponding mutant tau conditions. 
 
For all gliding assays, data were collected from multiple independent experiments using tau 
proteins purified from at least two independent preparations. 
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6. Kinesin-driven Quantum-Dot (QD) Assays  
For use in QD assays, taxol-assembled MTs were generated as above, except the incubation 
time between additions of taxol was extended to 20 min to generate longer MTs. 
Immediately after the final incubation, the MTs were pelleted in a benchtop centrifuge at 
14,000 rpm for 10 min at room temperature to remove unpolymerized tubulin, which 
contributes to background fluorescence. The pellet was gently resuspended in a stabilization 
buffer containing 1 mM GTP, 20 µM taxol, and 1 mM DTT in BRB-80, and stored at room 
temperature, away from light. MTs formed by this method are typically stable for up to one 
week. QD assays were performed as previously described [57], with modifications. Glass 
flow-chambers were constructed by attaching plasma-cleaned 22x40 mm #1.5 coverslips to 
clean glass microscope slides with two parallel pieces of double-sided tape spaced ~5 mm 
apart. β tubulin antibody (SC-58884, Santa Cruz Biotechnology Inc.) solution (40 µg/mL) 
was flowed into the chambers to allow absorption to the coverslip surface. After a 10 min 
incubation, excess antibodies were washed out by addition of 50 µL of BRB-80.  
 
The stock MT solution was diluted 1:20 in BRB-80, supplemented with 10 µM taxol, and 
20 µL of the MT solution was then flowed into the chambers. After a 10 min incubation 
period, 4 mg/mL casein solution was introduced to wash out any unattached MTs, and to 
passivate any remaining active glass surfaces. After 10 min, biotinylated kinesins, diluted to 
20 ng/mL in a solution of BRB-80 supplemented with 10 µM taxol and 1 mM AMPPNP, 
were introduced to the flow chambers. After 5 min, chambers were washed and Qdot® 605 
streptavidin conjugated quantum dots (Q10101MP, Invitrogen), diluted to 0.2 nM in BRB-80 
with 10 µM taxol, were introduced. After 5 min chambers were washed with a standard 
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motility buffer for single-molecule kinesin measurements, consisting of BRB-80 
supplemented with 10 µM taxol, 5 mM DTT, 1% β-mercaptoethanol, an enzymatic oxygen 
scavenger system as well as the desired type and concentration of tau protein (typically 100 
nM tau) [57]. The chambers were sealed with vacuum grease and visualized immediately. 
Considering the cylindrical geometry of the microtubule (outer diameter of ~ 25 nm) and the 
size of the QD (diameter ~ 20 nm) there can be no more than 4 motors accessible to any QD 
that diffused near a microtubule during the QD loading step, and our run length 
measurements suggest that at least two motors are engaged. Based on our estimates for the 
molar ratio of polymerized tubulin dimer to kinesin dimer in the observation chamber of 
approximately 25:1 we believe that on average, 2-3 kinesin molecules are available to bind 
each QD during complex assembly. Motors are bound to the QD using a biotin-streptavidin 
linkage, which has a near covalent bond strength, and thus a bond lifetime that is much 
longer than our experimental observation. 
 
7. Data Acquisition and Analysis: MT Gliding Assay  
For taxol-assembled MTs, gliding events were visualized using a Nikon Ti-S microscope 
equipped with custom-built total internal reflection fluorescence (TIRF) illumination 
capabilities (100× magnification, 67 nm/pixel, 19-20°C ambient temperature). Excitation 
wavelength used for rhodamine imaging was 532 nm. Images were collected using an air- 
cooled EMCCD camera (Andor, iXon) every 0.4 s for 100 frames. MT tracking was 
performed manually using ImageJ to identify the leading tip of the moving MT in each 
frame. To calculate velocity, the total MT trajectory length was divided by the time interval 
over which motion was observed.  
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For tau-assembled MTs, gliding events were visualized by exciting the rhodamine-labeled 
MTs at 460 nm. MTs were warmed to 35°C using an objective heater (Bioptechs) and 
microscope stage warmer (Okolab). A Hamamatsu Orca II digital camera connected to a 
Nikon Eclipse E800 fluorescence microscope at 60x magnification (106 nm/pixel) was used 
in conjunction with Metamorph imaging software (Molecular Devices) to capture an image 
stack of 30 full frame images using a 4 s interval between acquisitions and a 200 ms 
exposure time (without binning). Velocity measurements were performed using the ImageJ 
‘Manual Tracking’ plug-in (Fabrice P. Cordelieres, Institute Curie, Orsay, France; version 
2005/06/15). Only MTs which had plus ends and minus ends visible throughout the entire 
process of tracking were selected for analysis. Frame to frame velocity was collected for ~20 
frames, and then used to calculate an average velocity for each MT. 
 
8. Data Acquisition and Analysis: QD Assay 
Motions of single QDs were visualized using a custom-built total internal reflection 
fluorescence (TIRF) microscope at 100× (magnification = 67 nm/pixel). Images were 
collected at room temperature using an air- cooled EMCCD camera (Andor, iXon) at a rate 
of 10 frames per s (full frame transfer). Excitation wavelength used for QD imaging was 488 
nm. A broadband emission filter was selected to allow the dim outline of the rhodamine-
labeled MT to be observed in the background of the bright QD images. Images were 
analyzed off-line after data collection. Movies were manually screened to identify the motion 
of kinesin-driven QDs that warranted velocity analysis. Only runs that persisted for at least 
30 frames were analyzed. QD position was determined as a function of time using the built-in 
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FIONA algorithm available through Video Spot Tracker software (made available by 
CISMM at UNC-CH, supported by the NIH NIBIB, Award# NIH 5-P41-RR02170).  
 
The initial velocities of the kinesin-QD assemblies were calculated framewise then refined to 
discriminate between motions that were parallel or perpendicular to the MT axis using a 
graphic-based analysis algorithm implemented in MATLAB. This was particularly useful for 
cases in which tau binding disrupted the antibody-MT connection, leading to thermal 
fluctuations of the MT substrate upon which the kinesin motors walk. For each moving 
kinesin-QD assembly, a region with a width of 15 pixels was drawn around the trajectory, 
and the fluorescence intensity over the run duration was accumulated to obtain a single image 
displaying the average location of the underlying MT track. The MT location was then 
determined by fitting a Gaussian curve to the cross-section of intensity of the MT contour 
using ~ 100 evenly distributed points, as previously described [58, 59]. Curve fitting was 
implemented using built-in curve-fitting algorithms in MATLAB. Using the resulting MT 
coordinates, the initial velocities were projected into two orthogonal components, one 
parallel and one perpendicular to the MT contour. The kinesin velocity for a single 
translocation event (i.e., a single ‘run’) was given by the mean of the parallel components of 
the framewise velocities. To determine run length, the total distance moved by each kinesin-
coated QD was determined manually using built-in measurement tools in ImageJ. 
 
D. Results 
The goals of our work are (i) to determine how disease-linked tau mutants affect the ability 
of MTs to support kinesin translocation, and (ii) to determine the extent to which these 
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effects are enhanced or diminished by the presence of taxol. To accomplish these goals, we 
used two complementary in vitro assay geometries. In the MT gliding assay, kinesins are 
physisorbed to glass coverslips and the motor domains that extend into solution interact with 
freely diffusing MTs. As a result, MTs are propelled across the surface by a large ensemble 
of motors acting in concert. Individual MTs are visualized by microscopy and their velocities 
quantitated. In the quantum dot (QD) assay, small numbers of kinesin dimers (typical 2-3) 
are bound to QDs in a manner that mimics in vivo cargo attachment. In this case, single MTs 
are immobilized on a coverslip surface using anti-tubulin antibodies in order to promote a 
natural tubulin conformation. QD movement is visualized by microscopy and their velocities 
quantitated. 
 
For the gliding assays, we used two different MT preparations - MTs were assembled by 
either tau alone (without any taxol) or MTs were assembled by taxol and subsequently coated 
with tau. Traditionally, MT gliding assays have been performed at room temperature and 
with taxol assembled MTs because taxol confers significant stability upon otherwise dynamic 
MTs. On the other hand, using tau assembled MTs provides a more biologically relevant 
condition. Because the absence of taxol reduces MT stability at room temperature, our tau-
assembled MT gliding assays lacking taxol were performed at 35°C with the addition of a 
small amount (8%) of glycerol to suppress MT dynamics. With respect to the QD assay, 
these were performed at room temperature using taxol-assembled, tau-coated MTs because 
the antibody used for MT anchoring is unstable at 35°C. Despite this limitation, the 
measurement of the motions of individual QDs provides important mechanistic insights not 
available through the gliding assay, including the identification of pauses and the 
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characterization of cargo travel distance (“run length”) as well as variations in cargo velocity. 
To ensure reproducibility, we repeated each measurement using at least two independent tau 
preparations for each protein tested, and presented mean velocities that were averaged over 
numerous independent observations (for more details, see Materials and Methods). 
 
1. Differential effects of 3R WT and 4R WT tau on kinesin translocation in the absence 
and presence of taxol 
Prior to examining mutant tau proteins, we first examined the effects of 3R WT tau and 4R 
WT tau on kinesin translocation. There is a substantial literature of the effects of WT tau on 
kinesin motion in vitro [7, 28, 33, 34] which our study extends in two important ways. First, 
we compared the effects of the 3RS and 4RS isoforms of tau, allowing the effects of the two 
different microtubule binding repeat regions to be assessed when adjacent to the same N-
terminal region of tau, i.e., both 3R and 4R tau were examined in the “short” projection 
domain context. Second, we directly examined the effects of taxol by assembling MTs with 
and without the drug present. In agreement with our prior work [50], we found that MTs 
assembled by 3R WT tau glide significantly faster than MTs assembled by 4R WT tau in the 
absence of taxol (Tables 3-2). Interestingly, for MTs assembled by taxol and coated by tau 
this gliding rate difference was reversed (Tables 3-2). Additionally, taxol-assembled MTs 
lacking tau glided faster than those coated with either WT tau isoform.  
 
To gain additional insight into the mechanism of kinesin action, we next tested 3R WT tau 
and 4R WT tau using the QD assay. In agreement with the gliding assays, kinesin-QD 
complexes translocated significantly faster along taxol MTs lacking tau than along taxol MTs 
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coated with either 3R or 4R WT tau (Tables 3-2); however there were no statistically 
significant differences in kinesin velocity between the 3R WT and 4R WT tau. In no case did 
we observe obvious periods of pausing or variation in velocity. There were no tau 
concentration-dependent effects on velocity for either tau isoform at concentrations in the 
range of 100–1000 nM (data not shown), consistent with previous results [7, 50].  
 
These data demonstrate that the effects of tau on kinesin-driven motility depend sensitively 
on the MT assembly conditions and also the geometry of the microtubule-kinesin attachment. 
In the gliding assay, MTs assembled by 3R WT tau support faster kinesin translocation rates 
than MTs assembled by 4R WT tau; however, for MTs assembled by taxol and then coated 
with tau, this effect is either absent or reversed. To better understand the influence of taxol 
and our experimental design, we repeated the MT gliding assay using taxol-assembled tau 
coated MTs under the temperature and glycerol conditions used in the taxol-free MT gliding 
assay (i.e., 35°C and 8% glycerol). We found that the differences observed between 4R tau 
assembled MTs (lacking taxol) and 3R assembled MTs (lacking taxol) previously observed 
under these conditions disappeared when comparing taxol assembled/tau coated MTs (data 
not shown). Thus, we conclude that MTs assembled by 3R WT tau and 4R WT tau 
differentially affect the rate of kinesin translocation, and that this effect can be masked or 
altered by the presence of taxol. 
 
2. Effects of neurodegeneration-linked tau mutations on the rate of kinesin translocation 
Before testing the effects of mutant tau proteins on kinesin translocation, we first assessed 
the ability of each WT and mutant tau protein used in this work to assemble MTs from 
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tubulin dimer subunits and to bind to pre-formed taxol assembled MTs using a MT 
cosedimentation assay. Tau was incubated with either tubulin dimers or taxol assembled MTs 
at tau to tubulin dimer molar ratios of 1:5 or 1:30, bracketing the approximate physiological 
range for neurons [60, 61]. In both cases, the four tau mutants P301L, ΔN296, 3R-R406W, 
4R-R406W demonstrated similar assembly and binding activities to their corresponding WT 
constructs (Figure 2-2). Consistent with previous results, we find that the ratios of tau:tubulin 
present in tau assembled MTs is somewhat higher than the ratios of tau:tubulin in the 
corresponding initial reaction mixture (especially at lower tau:tubulin molar ratios). This is 
not surprising since tau binds strongly to MTs but not to free tubulin dimers, and some 
tubulin remains in solution [50]. Based on these results, we argue that any differences 
observed in kinesin translocation along MTs assembled by, or coated with, these tau mutants 
must be due to inherent differences in tau action, rather than the result of differential tau-
mediated MT assembly or differential tau binding to taxol-assembled MTs.  
 
To begin assessing the effects of neurodegeneration-linked tau mutations on kinesin 
translocation, we first tested the effects of tau harboring the P301L point mutation. This 
mutation maps to exon 10, which is present only in the 4R tau context (Figure 2-1). When 
using tau-assembled MTs (without taxol), we observed a substantial ~ 33% reduction in 
gliding velocity of 4R P301L MTs relative to the 4R WT control MTs (Table 3-2). When 
using taxol-assembled, 4R P301L tau coated MTs, we found a consistent and statistically 
significant, albeit more modest, reduction (~8%) as compared to the 4R WT control when 
using the traditional gliding assay (Table 3-2). In the kinesin-QD assay, we observed a 
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modest but not statistically significant reduction in translocation velocity of kinesin-QDs on 
taxol MTs coated with 4R P301L tau relative to 4R WT tau.  
 
We next examined the ΔN296 tau mutation, which also maps to exon 10, and is therefore 
present only in the 4R tau context (Figure 2-1). With the tau-assembled MT gliding assay 
(without taxol), we observed a substantial reduction in MT gliding velocities (~23%) using 
MTs assembled by 4R ΔN296 tau relative to MTs assembled by 4R WT tau. In contrast, no 
differences in gliding rates were observed between taxol assembled MTs coated with 4R 
ΔN296 and those coated with 4R WT tau using the traditional gliding or kinesin-QD assays.  
 
We next tested the effects of the R406W tau point mutation on kinesin translocation. This 
mutation maps to the C-terminal tail of tau and is present in both 4R tau and 3R tau (Figure 
2-1). Using MTs assembled by tau (without taxol) we found a substantial ~17% reduction in 
the gliding velocity of 4R R406W tau-assembled MTs relative to 4R WT tau (Table 3-1). 
Again, this effect was abolished in the traditional gliding assay using taxol-assembled MTs. 
Surprisingly, the difference between 4R R406W and 4R WT was discernable in the kinesin-
QD assay; kinesin-QDs translocated 19% slower along taxol assembled MTs coated with 4R 
R406W tau relative to taxol assembled MTs coated with 4R WT tau. In marked contrast, 
none of the three assays revealed any reduction in kinesin translocation rate for the 3R 
R406W tau mutation, indicating a strong tau isoform-specific effect.  
 
In agreement with our parallel studies with the WT tau proteins, control experiments using 
each tau mutant demonstrated that the difference between the two MT gliding assays is due 
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to the presence of taxol, rather than changes in temperature or the presence of glycerol (data 
not shown). Taken together, our data indicate that MTs assembled by 4R P301L, 4R ΔN296, 
and 4R R406W tau support slower rates of kinesin translocation as compared to MTs 
assembled by 4R WT tau. Moreover, we find that the presence of taxol can suppress these 
effects, and that the magnitude of the suppression appears to be sensitive to the geometry of 
the assay.  
 
Finally, reductions in kinesin translocation rates were not observed with all tau mutants 
tested. We found that 4R ΔK280 tau, 4R P301S tau and 4R G303V (Figure S1) all (i) 
assembled MTs, and bound to taxol MTs, similarly to 4R WT tau (Figure S2) and (ii) did not 
slow the rate of kinesin translocation rate as assessed using the taxol-free tau assembled MT 
gliding assay, the assay in which we found the most dramatic effects for the P301L, ΔN296, 
and 4R R406W mutants (Supplemental Table S1). Specifically, the gliding velocity of 4R 
P301S tau MTs was statistically indistinguishable from that of 4R WT tau assembled MTs, 
whereas MTs assembled by either 4R ΔK280 tau or 4R G303V tau supported slightly (~8%) 
faster gliding speeds than 4R WT tau assembled MTs. 
 
3. Effects of the tau proteins on kinesin-QD travel distance 
As another assessment of kinesin translocation, we measured the distance traveled by the 
kinesin-QDs during single translocation events (i.e., “run length”). This parameter is not 
measurable using a MT gliding assay, since new motors are continually engaged as the MT 
glides across the kinesin-decorated surface. In contrast, the QD accommodates a small 
number of kinesin motors (based on the QD size of ~20 nm, we estimate that 2-3 molecules 
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of kinesin are typically engaged), and therefore the kinesin-QD run length can be a useful 
metric when comparing MTs coated with different tau isoforms. Assuming that each motor 
operates independently, the probability of detachment of cargo from the MT depends on the 
product of detachment probabilities of each motor [62]. In the case of single kinesin motors 
moving along bare taxol-stabilized MTs, the probability of detachment is ~ 10-2 per step. 
Given an 8-nm step size, this leads to an average run length of ~ 800 nm. When two motors 
are simultaneously engaged, the predicted run length increases to 80 µm, much longer than 
the average MT used in our studies. Consistent with this, in the absence of tau, >90% of the 
kinesin-QD assemblies bind and translocate to the end of taxol assembled MTs. Therefore, 
the observed run length of taxol assembled MTs (~ 8 µm; Figure 2-3) is given by one-half of 
the average MT length, and is a substantial underestimate of the actual run length of the 
assembly.  
 
In the presence of 3R or 4R WT tau, the percentage of kinesin-QD assemblies that bind and 
move to the end of the MT drops to ~50%, and the mean run length decreases by a factor of 
two to ~3.2–3.5 µm (Figure 2-3). This is consistent with prior work demonstrating that WT 
tau proteins tend to promote kinesin detachment (or inhibit reattachment) [7, 34]. 
Interestingly, there was a slight increase in run length in the presence of the P301L and 
ΔN296 mutants, but no significant effect of either 4R R406W tau or 3R R406W tau 
mutations on run length, all in comparison to their respective WT tau isoforms. These results 
suggest that velocity decreases for the R406W and P301L mutations observed with the QD 
assay do not correlate with enhanced kinesin dissociation from the MT. 
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Figure 2-1: Schematic of the two wild-type (WT) tau isoforms used in this study, showing 
the projection domain, microtubule binding repeat (MTBR) region and the C-terminus of 
each. These two isoforms differ by the presence (4RS) or absence (3RS) of the alternatively 
spliced exon 10, comprising repeat two (R2) and the inter-repeat between R1 and R2. All tau 
proteins used in this study lack the two alternatively spliced exons (exons 2 and 3) in the 
projection domain, i.e., all were the “short” isoforms. These isoforms are abundantly 
expressed in both development and maturity. Positions of point mutations that affect kinesin 
translocation are noted.  
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Figure 2-2: Cosedimentation assays comparing the tau:tubulin molar ratio in tau-assembled 
and taxol-assembled/tau coated MTs achieved by WT and mutant tau proteins. Two 
tau:tubulin ratios were used to assemble MTs 1:5 and 1:30, which span the physiological 
range in neurons. Following the assembly reactions, the samples were sedimented, the pellets 
containing assembled MTs were recovered and then assayed for tau and tubulin content. In 
each case, mutants were statistically compared with their corresponding WT isoform. 
Overall, all mutants in a given assay bind with an affinity that is similar to that of their 
corresponding WT tau, although one difference was statistically significant in one P301L 
assay at *P< 0.05. Error bars are SEM. 
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Figure 2-3: Kinesin-QD run length on MTs assembled by taxol and coated with various WT 
or mutant tau proteins. In control experiments using taxol assembled MTs lacking any tau, 
the run length was determined by the average MT length, since ~90% of kinesin-QD 
complexes walked to the end of the MT before dissociating. In the presence of 100 nM tau, 
the percentage of kinesin-QDs that walk to the end of the MT dropped to ~50%. We did not 
observe any mutation-dependent reduction in kinesin run length, suggesting that kinesin-MT 
dissociation is not substantially enhanced in the presence of disease-linked tau isoforms.  
Error bars are SEM; the number of samples per condition ranged from 24–54.  
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Table 3-1. Summary of velocity results for all conditions and assays 
Assay Condition Taxo v (m/s) N vmutant  ⁄ vWT p-value 
Gliding 4R WT − 0.48 ± 0.01 78 —  
 4R P301L − 0.32 ± 0.02 33 0.67 ± 0.04 <0.001 
 4R N296 − 0.37 ± 0.02 53 0.77 ± 0.04 <0.001 
 4R − 0.40 ± 0.01 34 0.83 ± 0.02 <0.001 
 3R WT − 0.54 ± 0.01 55 —  
 3R − 0.55 ± 0.01 49 1.01 ± 0.02 NS 
Gliding No tau + 0.36 ± 0.01 354 —  
 4R WT + 0.32 ± 0.01 155 —  
4R P301L + 0.30 ± 0.01 69 0.92 ± 0.09 <0.0001 
4R N296 + 0.32 ± 0.01 75 0.98 ± 0.09 NS 
4R + 0.33 ± 0.01 76 1.01 ± 0.09 NS 
3R WT + 0.29 ± 0.01 100 —  
3R + 0.32 ± 0.01 57 1.10 ± 0.13 <0.0001 
QD No tau + 0.43 ± 0.01 93 —  
 4R WT + 0.33 ± 0.02 38 —  
 4R P301L + 0.30 ± 0.02 39 0.91 ± 0.08 NS 
 4R N296 + 0.36 ± 0.03 19 1.07 ± 0.11 NS 
 4R + 0.27 ± 0.02 57 0.81 ± 0.07 <0.05 
 3R WT + 0.36 ± 0.02 40 —  
 3R + 0.36 ± 0.02 44 0.99 ± 0.07 NS 
N is number of measured MTs or QDs at each condition. All errors are SEM. P-values are 
calculated for each protein that shows a significant difference in velocity using the 
Student’s t-test at a 95% confidence level. For each mutant tau, the statistical comparison is 
made between the velocity measured using MTs assembled by, or coated with, the mutant 
tau as compared to MTs assembled by, or coated with, WT tau of the same isoform. NS = 
Not significant. Statistical data comparing the velocities measured using MTs assembled 
by, or coated with, 3R and 4R WT proteins, or comparisons with the velocity measured 
using taxol-assembled MTs lacking tau are shown in Table 2. 
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Table 3-2. Statistical comparison of the velocities for MTs assembled by WT 
Assay Taxol Condition1 Condition2 p-value 
Gliding + No tau 3R WT <0.0001 
 + No tau 4R WT <0.0001 
+ 3R WT 4R WT <0.0001 
QD + No tau 3R WT <0.001 
 + No tau 4R WT <0.001 
 + 3R WT 4R WT NS 
Gliding − 3R WT 4R WT <0.001 
P-values are calculated for each protein that shows a significant difference in velocity using 
the Student’s t-test at a 95% confidence level. In each case, the statistical comparison is made 
between the velocity measured in “Condition 1” versus the velocity in “Condition 2”. NS = 
Not significant. Velocity data and number of samples are shown in Table 2. 
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E. Discussion 
We sought to test the hypothesis that mutant tau proteins known to cause neurodegeneration 
and dementia can alter the normal pattern of kinesin translocation along MTs, thereby 
negatively impacting the essential process of axonal transport. Our strategy was to employ 
complementary in vitro assays composed entirely of defined components, i.e., purified 
recombinant kinesin, purified recombinant tau (WT or mutant), purified bovine α:β tubulin, 
and in some cases taxol. This allowed the interactions among just these components to be 
assessed, without complicating contributions from complex cellular regulatory mechanisms 
(i.e., phosphorylation). The major observations presented here are (i) that kinesin translocates 
slower along MTs assembled by any of three independent tau mutants (4R P301L tau, 4R 
ΔN296 tau and 4R R406W tau,) relative to its translocation rate along MTs assembled by 4R 
WT tau, (ii) that the R406W tau mutation has tau isoform specific effects, i.e., while kinesin 
translocates slower along 4R R406W tau assembled MTs than along 4R WT tau assembled 
MTs, no such difference is observed between 3R R406W tau and 3R WT tau assembled 
MTs, and finally (iii) that assembling MTs with taxol followed by coating with tau often 
obscures, and in some cases abolishes, effects of tau mutants that are readily apparent using 
more physiologically relevant MTs assembled with tau alone. Taken together, these data 
demonstrate that mutant tau proteins known to cause neurodegenerative disease, including 
P301L tau, ΔN296 tau and 4R R406W tau, can alter the normal pattern of kinesin 
translocation along MTs, and provide support for the hypothesis that altered axonal transport 
could underlie at least one component of tau-mediated neuronal cell death and dementia in 
the tauopathies. Altered patterns of kinesin translocation could promote cell distress in 
numerous ways (such as improper distribution of essential proteins/organelles and/or 
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oxidative stress), which in turn could promote neuroinflammation and subsequent 
neurodegeneration [63]. 
 
One plausible mechanism of differential tau action (WT tau vs. mutant tau; 3R WT tau vs. 
4R WT tau) is that MTs assembled by different tau proteins vary in their structures, which in 
turn affects kinesin translocation. This view is consistent with prior tau structure-function 
studies. P301L and ΔN296 map to the region of tau that interacts directly with MTs [37, 39, 
64, 65]. It is therefore reasonable to suggest that mutant tau assembled and stabilized MTs 
are structurally and functionally distinct from WT tau-assembled MTs, leading to the slowing 
of kinesin velocities that we observe. The third mutation, R406W, maps downstream of the 
region possessing regulatory activities for MT assembly and MT dynamics, and its molecular 
basis of pathological action is unclear. R406W mutant tau was indistinguishable from WT 
tau with respect to regulating MT function in a heterologous expression system [66] and in 
the regulation of MT dynamics either in vitro [67] or in cultured cells [68]. These 
observations led investigators to suggest that R406W might cause neurodegeneration and 
dementia indirectly, for example, by altering the ability of regulatory kinases and/or 
phosphatases to interact with nearby phosphorylation sites [66-68]. However, given the fact 
that our current assay systems contain only purified tau, kinesin and tubulin, our data argue 
for some kind of direct action by the R406W mutant protein, but only in the 4R tau context. 
Consistent with tau isoform specific action of the C-terminal region of tau in which the 
R406W mutation resides, it has been shown that the C-terminal region of tau differentially 
affects the MT binding capabilities of 3R and 4R tau [69].  
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The fact that taxol can ameliorate, at least in part, the deleterious effects of mutant tau action 
is consistent with earlier work demonstrating that taxol induces structural and functional 
effects upon MTs [42, 44, 46, 70]. Interestingly, taxol and tau have many similar effects upon 
MTs [40, 44, 53, 64, 71] and data suggests that tau and taxol bind to very close (perhaps 
overlapping) sites on the inside surface of MTs [4, 72]. Perhaps the presence of taxol serves 
to complement mutant tau action, inducing structural effects that at least partially compensate 
for the inability of mutant tau to generate a WT tau structure for MTs? In this regard, it is 
notable that the MT stabilizing drug epothilone D is under study as a possible therapeutic for 
Alzheimer’s and related dementias [73, 74]. The effect of taxol in the case of the 4R R406W 
mutation is particularly intriguing since we find that the gliding assay shows no velocity 
reduction with respect to WT tau in the presence of taxol, whereas the QD assay shows 
reduction of the same magnitude as was observed using tau-assembled MTs without taxol. 
The origin of these differences is not yet clear, although it is possible that the 4R R406W 
mutation causes a conformational change in the C-terminal region of tau creating an unusual 
MT surface topology, and that small numbers of kinesin molecules (coupled to the QD) are 
more sensitive to this change than are large groups of kinesin motors (all bound to the MT) in 
the gliding assay.  
 
The observation that taxol often obscured the effects of mutant tau upon kinesin translocation 
along MTs is somewhat troubling from a purely experimental point of view, since taxol has 
been used extensively to study many aspects of MT biochemistry and cell biology. For the 
vast majority of these studies, it has been assumed that taxol assembled MTs were simply 
‘generic’ MTs. However, there may be subtle, effector-mediated changes in MT structure 
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that impact MT function in important ways that we are just beginning to understand. It may 
therefore be prudent to minimize the use of taxol assembled MTs in future work investigating 
the effects of tau and other MAPs on MT structure and function, and previous work using 
taxol assembled MTs may require re-assessment for possible taxol-dependent effects. 
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III. Spectral Analysis Methods for the Robust Measurement of the 
Flexural Rigidity of Biopolymers2 
The study in this section was conducted in collaboration with Paul Atzberger’s research 
group, Department of Mathematics, UCSB. All information was published in Biophysical 
Journal in 2012 [59]. All supplemental materials can be found on publisher’s website site.   
 
In this chapter, we will discuss the new and improved spectral analysis method that we 
developed to robustly measure the flexural rigidity and persistence length of semiflexible 
biopolymers such as microtubules. 
 
A. Abstract 
The mechanical properties of biopolymers can be determined from a statistical analysis of the 
ensemble of shapes they exhibit when subjected to thermal forces. In practice, extracting 
information from fluorescence microscopy images can be challenging due to low signal/noise 
ratios and other artifacts. To address these issues, we develop a suite of tools for image 
processing and spectral data analysis that is based on a biopolymer contour representation 
expressed in a spectral basis of orthogonal polynomials. We determine biopolymer shape and 
stiffness using global fitting routines that optimize a utility function measuring the amount of 
fluorescence intensity overlapped by such contours. This approach allows for filtering of 
high-frequency noise and interpolation over sporadic gaps in fluorescence. We use 
benchmarking to demonstrate the validity of our methods, by analyzing an ensemble of 
                                                 
2 Reprinted from Biophysical journal 102 (5), Valdman, Yu, et al., Spectral analysis methods for the robust 
measurement of the flexural rigidity of biopolymers, 1144-1153, Copyright (2012), with permission from 
Elsevier. 
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simulated images generated using a simulated biopolymer with known stiffness and 
subjected to various types of image noise. We then use these methods to determine the 
persistence lengths of taxol-stabilized microtubules. We find that single microtubules are 
well described by the wormlike chain polymer model, and that ensembles of chemically 
identical microtubules show significant heterogeneity in bending stiffness, which cannot be 
attributed to sampling or fitting errors. We expect these approaches to be useful in the study 
of biopolymer mechanics and the effects of associated regulatory molecules. 
 
B. Introduction and Background 
Cytoskeletal polymers, including actin and microtubules, are stiff, multistranded filaments 
that are essential to cell organization, motility, and division; to the transport of intracellular 
cargos by motor proteins; and to the generation and transmission of forces within and across 
cells. Because of their important role in establishing and regulating cellular mechanics, the 
elasticity of filaments and entangled cytoskeletal networks has been studied extensively. 
However, many important questions remain about the relationships between structure and 
mechanics [75]. In particular, although in vitro measurements of single filament elasticity 
have consistently shown significant variations in stiffness over roughly an order of 
magnitude, the molecular origins of these variations are incompletely understood [76-81]. 
This is largely a result of an inability to distinguish real heterogeneity in elasticity from 
variations that arise from sources of experimental and statistical uncertainty.  
 
For microtubules (MTs), the stiffest cytoskeletal filaments, distinguishing between signals 
and noise is particularly challenging because the exhibited bending amplitudes are small and 
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often of a comparable magnitude to experimental noise. MTs are formed from the head-to-
tail polymerization of tubulin dimers in long protofilaments that interact laterally to form a 
closed tubular structure, with outer diameter of roughly 25 nm [4, 5, 82, 83]. Structural 
studies have demonstrated that the number of MT protofilaments varies within in vitro and in 
vivo systems, and can even change along the length of a single MT [84-86]. Because the 
bending stiffness of a biopolymer scales as the fourth power of its radius, even small changes 
in the effective radius of the MT could have a large mechanical effect. Under some in vitro 
conditions, MT stiffnesses appear to depend on both the length and the polymerization 
velocity, suggesting that lattice shear and structural defects may also play an important role 
[79, 87-89]. Unfortunately, the large variation in experimental estimates of MT stiffness 
values has severely compromised our ability to correlate changes in mechanical response and 
filament composition, and has led to an incomplete understanding of the origins and 
regulation of MT mechanics. 
 
To help address these issues, we have developed what to our knowledge are new methods to 
determine and analyze the motions of stiff, isolated, thermally fluctuating biopolymers 
visualized using fluorescence microscopy. Using approaches from statistical mechanics, we 
then infer mechanical properties from a spectral analysis of the ensemble of biopolymer 
configurations at thermal equilibrium. A central challenge in using this approach is the 
sensitivity of the spectral analysis methods to experimental noise 
[58, 78]. Previous methods to characterize the fluctuation spectra of biopolymer filaments 
made use primarily of local information in the fluorescent image, and typically involved 
three distinct operations: Step 1. Filament tracing to determine biopolymer configurations. 
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Step 2. Calculation of spectral components from estimated contours. Step 3. Analysis of the 
spectral components using statistical mechanics to ascertain mechanical properties [58, 78, 
79]. Step 1 typically involved interpolating individual configuration points that were 
determined by manual selection or by local fitting of the cross-sectional intensity profiles of 
fluorescently labeled filaments [58, 78, 79]. Because each control node is fit independently, 
any local aberration (such as irregularity in fluorophore labeling or the interference of a 
nearby physical object) in the image near a control point could have a large influence on the 
entire fitted contour. Though these approaches have been successfully employed to provide 
important mechanical information for many types of biopolymers, for the stiffest 
biopolymers, results vary by roughly an order of magnitude, motivating the development of 
improved fitting and analysis methods [81, 90].  
 
In this work, we develop a unified approach that combines Steps 1 and 2 into a single 
procedure, thus minimizing the introduction of errors. This is achieved by representing the 
biopolymer shape in terms of a contour expanded in an orthogonal polynomial basis. We fit 
the coefficients of the expansion directly to the fluorescence image by optimizing a utility 
function that measures the overlap of the entire contour with fluorescence intensity. This 
global approach is more robust to local disturbances in the fluorescence signal, and allows 
for the determination of biopolymer shape even in the presence of significant noise and 
artifacts in the images. To estimate the flexural rigidity of the biopolymer, we develop a 
statistical mechanics theory based on an energy formulated directly in terms of the 
coefficients of our spectral biopolymer representation.  
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Our approach has a number of distinct advantages. The description of the biopolymer by a 
smooth contour that is fit to the entire image at once naturally handles sporadic gaps in 
fluorescence intensity along the biopolymer through interpolation, and shows improvement 
in both filament tracing and determination of persistence length as compared to pointwise 
tracing. Because these methods are more robust against common sources of experimental 
noise, it is possible to analyze a larger number of images, giving rise to smaller sampling 
errors and improving measurement precision. Additionally, we achieve a more accurate 
description of the biopolymer near the end-points through the use of a basis of orthogonal 
polynomials. This is in contrast to the use of a trigonometric Fourier basis that implicitly 
requires a periodic function, and thus a no-curvature condition at the contour end-points to 
reduce spurious oscillations arising from Gibb’s Phenomena [58, 78, 91]. Our method can, in 
principle, allow for curvature near the end-points, and could potentially facilitate studies of a 
wider class of biopolymers.  
 
To assess the sensitivity of the proposed methods to experimental noise and sampling error, 
we introduce a benchmarking approach in which an ensemble of simulated images is 
generated from simulations of a fluctuating biopolymer with known mechanical properties. 
We introduce noise and artifacts into the images that are similar to those observed in 
experimental data. This approach allows for the systematic study of the roles played by 
different types of experimental noise, and the resultant uncertainty of estimated mechanical 
properties. The benchmarking approach we propose provides a potentially powerful metric 
for rating different spectral analysis methods and for understanding the statistical 
significance of differences reported in experimental results. We then apply the techniques to 
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an experimental data set of fluorescence images of fluctuating MTs. For even these stiff 
biopolymers, we find our methods reliably estimate the flexural rigidity and produce modal 
covariances in agreement with a wormlike-chain (WLC) model for MT mechanics. 
Interestingly, we find that the level of heterogeneity in persistence length in an ensemble of 
chemically identical MTs vastly exceeds that predicted from algorithmic error analysis, 
indicating that significant structural heterogeneity may be present in these samples. We 
anticipate that these approaches will facilitate the development of more sensitive assays 
based on the thermal fluctuations of biopolymers, and will enable central questions 
concerning the molecular origins of cytoskeletal mechanics to be answered. 
 
C. Methodology 
1. Variational contour fitting method 
In developing this method, we have designed our algorithm for use with images of stiff, 
isolated filaments, such as MTs, in which a direct determination of the tangent-angle 
decorrelation function is not possible. Instead, we use information obtained from a 
description of the biopolymer shape in terms of a curve x(s) of length L, where s ∈ [0,L] is 
the arc-length parameter of the contour. To measure how well the contour x overlaps with the 
fluorescence signal of the biopolymer, we use the utility function 
 
The fluorescence image intensity is given by I = I(y) parameterized over the spatial domain 
Ω and k(r) is a smoothing kernel vanishing for r > r0. The inner-integral of Eq. 1 gives the 
average intensity in a region near the location x(s) by using the weighting specified by k(r). 
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The outer-integral collects these values to provide a measure of the total amount of overlap 
of a contour with the biopolymer fluorescence signal. The convolution by k(r) with I filters 
the high spatial-frequency noise inherent in the image intensity. 
 
We use the following kernel function (see Fig. 3-1), which has a number of desirable 
properties when used for discrete pixel maps and lattice models (see [92, 93]): 
 
Here, r0 is chosen to be approximately equal to the width of the imaged polymer. In the case 
of MTs, with a diameter of ~25 nm, r0 is taken to be approximately equal to the width of the 
point-spread function of the microscope. The α is a normalization constant ensuring the 
kernel function weighting integrates to one. 
 
The contour configuration that minimizes the utility function U provides a fit that maximizes 
the overlap within the image between the contour and the biopolymer fluorescence signal. 
This minimization requires a representation for the contour amenable to calculations, so we 
represent the contour by its tangent angle θ(s) along the length and by a reference point at the 
left end-point x0 = x(0). These physically meaningful degrees of freedom uniquely specify 
the contour curve x(s), 
 
The tangent vector τ for a given angle q is given by 
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This representation is used to minimize the utility function by evolving the degrees of 
freedom (θ(s), x0) using the steepest-descent dynamical equations 
 
The term δU/δθ denotes the variational derivative of the utility function, which generalizes 
the usual vector derivative and captures how values change when the entire collection of 
tangent vectors along the contour are varied [94]. The ׏࢞బܷ denotes the usual vector 
derivative in x0 of the utility function. 
 
It can be shown that for all possible variations of (θ(s), x0), the direction in configuration 
space giving the most rapid decrease in the utility function U is the negative of the gradient 
 
This motivates the choice for the dynamics, which ensures the contour configuration moves 
in a manner that steadily decreases the value of U over time. The limiting contour 
configuration that is stationary under these dynamics has a zero gradient and is a critical 
point of the utility function U. Such a contour is a candidate for minimizing U [94]. 
 
To work with this description in practice, we expand the tangent angles in an orthogonal 
polynomial basis 
 
Each Tn(s) is a polynomial of degree n satisfying the orthonormal inner-product condition < 
Ti,Tj >= δij, where δij is the Krӧnecker delta-function. The Tn values are shown in Fig. 3-2. In 
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practice, this expansion is truncated after a finite number of terms N, allowing for 
representation up to degree N polynomials. Dynamical equations are obtained readily for the 
coefficients ܽ௡ሺݐሻ by plugging this expansion into Eq. 4 and projecting the direction of 
evolution on the polynomials up to degree N (see the Supporting Material). 
 
A particularly useful feature of this coefficient representation is that even when only a finite 
number of coefficients are used, the contour recovered by Eqs. 3 and 5 has total arc-length L 
throughout the minimization procedure. Experimentally, this is a very reasonable constraint, 
as MT length is typically held constant by the use of small molecule inhibitors (such as taxol) 
during the course of the measurement. Although the total length of the polymer is held 
constant, the fitted contour can slide freely within the fluorescence signal of the illuminated 
filament during fitting. In practice, we determine the filament length from the average of the 
length of the contours obtained from our initial fits, then truncate by a fixed amount 
(typically by 10–20% of the initial length) to obtain a working length for final fitting. This 
truncation is implemented to avoid possible high-frequency oscillations that can sometimes 
arise due to compression of the fitted contour within the polymer after photobleaching has 
dimmed the fluorescence signal at the polymer ends. Even in the absence of spurious 
oscillations, the fluorescence signal at the ends of the microtubule tends to be of poor quality. 
By using a slightly shortened fitting contour, we avoid corrupting the spectral results with 
MT blurring and other imaging artifacts. Using benchmarking, we have determined the effect 
of contour truncation on the calculated persistence length, and for the simulated and 
experimental images analyzed here, the errors are typically <2–3%. 
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In presenting our approach, we use throughout the Chebyshev orthogonal polynomials 
defined by 
 
(see Trefethen (21)). This choice was motivated by the ability to take advantage of fast 
Fourier transform methods; however, other orthogonal polynomial bases could also be used. 
For more details concerning the particular forms of the variational derivatives used and 
truncation of the dynamics for a finite number of coefficients, see the Supporting Material. 
 
2. Determining persistence length from the spectrum of biopolymer fluctuations 
Using results from equilibrium statistical mechanics, we can estimate the elastic properties of 
isolated, thermally fluctuating biopolymers [78]. We focus here on determining the 
persistence length; however, these methods can be applied more generally to other 
mechanical moduli. To describe the elastic responses of biopolymers, we use the WLC 
model [95], which associates to a given biopolymer configuration x(s) a bending energy 
 
The EI denotes the flexural rigidity and ߠሶሺݏሻ ൌ ݀ߠ/݀ݏ denotes the derivative of the tangent 
angle in s. For an isotropic elastic structure, EI is the product of the Young’s modulus E and 
the geometric moment of inertia I. At thermodynamic equilibrium, the biopolymer thermal 
fluctuations have a Gibbs-Boltzmann distribution with the probability density 
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where T is the temperature, kB is the Boltzmann constant, and Z denotes the partition function 
(see Reichl [96]). 
 
Using our representation of the biopolymer configuration x(s) in terms of coefficients of the 
orthogonal polynomial expansion (see Eq. 5), the energy can be expressed as 
 
The term a denotes the composite vector of coefficients with [a]n = ܽ௡ and S denotes the 
stiffness matrix of the biopolymer modes. The entries Sij are given by the L2-inner product of 
the orthogonal polynomials with index i and j, so the matrix is not necessarily diagonal. For 
example, for our choice of Chebyshev polynomials the off-diagonal entries of S are nonzero. 
 
The Gibbs-Boltzmann distribution can be expressed using this coefficient representation as 
 
where Lp = EI/kBT gives the persistence length of the correlations of fluctuations along the 
contour and ෨ܼ is the partition function of this representation. Throughout, we treat the metric 
of the generalized coordinates as constant. In this form, we see that ρbend has the convenient 
form of a multivariate Gaussian with mean zero and covariance 
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In our analysis, we find it convenient for finite contours of length L to define a 
nondimensional persistence length lp = Lp/L. The covariance structure for biopolymer 
fluctuations derived from the WLC model and Eq. 10 is given by 
 
We have used the nondimensional WLC stiffness matrix defined by ሚܵ ൌ ܮܵ. This provides a 
covariance structure predicted by the WLC model when the nondimensional persistence 
length is lp. 
 
In experiments, the covariance is estimated by fitting contours to the fluorescence images and 
estimating modal coefficients. For M samples, the covariance is estimated by 
 
The a(m) denotes the mth sampled modal coefficient. 
 
A central relation we use to interpret experimental fluctuations of a biopolymer and to infer 
its mechanical properties is 
 
This expression provides the key link between observed biopolymer fluctuations (left-hand 
side) and the biopolymer mechanical properties (righthand side). To infer mechanical 
properties in experiments, we seek to find a value of lp so that Cwlc matches, to a good 
approximation, the covariance of the experimentally observed biopolymer fluctuations Cexp. 
 
This requires minimizing the least-squares error given by 
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In principle, any one entry in the covariance matrix could be used to determine persistence 
length, although it is possible to make use of redundant terms to increase accuracy (because 
there is sampling error in the coefficients), at the expense of additional computation time. We 
find in practice that it is sufficient to consider just the diagonal entries, thus the cn = [Cexp]n,n 
are the diagonal entries of the covariance matrix for the experimentally observed biopolymer 
fluctuations. The ݀௡ ൌ ሾ ሚܵିଵሿ௡,௡ are the coefficients used for representing the covariances 
obtained from the WLC model (see Eq. 11). The fit for lp is obtained by minimizing V(lp) and 
is given by 
 
We use composite vector notation for the experimental covariance data [c]n = cn and for the 
coefficients of the WLC model [d]n = dn, 
 
We remark that other approaches making use of additional features beyond the covariance 
matrix of the WLC model could also be used to estimate the persistence length, such as the 
maximum-likelihood method [97]. 
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Figure 3-1: Schematic of the methodology. (A) The intensity of the fluorescence signal of 
the biopolymer (inset) and the fluorescence microscopy image being fit by a trial contour 
(solid line). (Arrows) Direction of evolution of the trial contour when using the method of 
steepest descent for the utility function given in Eq. 1. (B) The radially symmetric kernel 
function k(r) having cut-off radius r0 (indicated by dotted circle). (C) Close-up of 
fluorescence image data within the range of influence given by r0. In this case, the 
fluorescence image exhibits gaps in intensity along the biopolymer that are handled naturally 
by the utility function and the inherent interpolation of the trial contour. 
 
 
Figure 3-2: Representation of the biopolymer shape using orthogonal polynomials. (A) The 
contour tracing out the shape of the biopolymer is described by parameterizing the shape 
using arc-length s and the local angle θ(s) of the tangent vector t with respect to the x axis. 
The point x0 is used to uniquely determine the position of the contour. (B) To work with this 
description in practice, we expand q(s) in an orthogonal polynomial basis to obtain 
coefficients an. (C) We use the Chebyshev orthogonal polynomial basis for this purpose. The 
first four nonconstant orthogonal polynomial modes are shown. 
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C. Results and Discussion 
1. Role of sampling error on estimated persistence length 
There are two fundamentally independent sources of error to consider for this analysis. The 
first is the inherent problem of sampling error, where the derivation of mechanical quantities 
leads to errors due to an averaging over a finite number of experimental observations. The 
second is the effect of different types of noise in the microscopy images on the estimated 
values of physical quantities. 
 
To determine the error in the estimated biopolymer persistence length lp in terms of the 
number of sampled images M, we assume a biopolymer exhibits fluctuations given by the 
WLC model, and estimate the covariance using Eq. 12. The sampling error can be expressed 
as 
 
The Cwlc (lp) denotes the covariance structure obtained from the WLC model in Eq. 7. For a 
sufficient number of samples, ξ is approximately a Gaussian with mean zero and covariance 
< ξξ T> = Cov(aaT)/M. Expressions for this covariance can be obtained by computing the 
fourth moments of the Gaussian distribution given in Eq. 7. The tilde notation will be used 
throughout to distinguish variables that model quantities that would be estimated 
experimentally. 
 
To simplify the presentation, we assume that the components of [a]n can be treated as 
statistically independent. Additionally, we describe our theory only for estimates of the 
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diagonal entries of the covariance matrix, which are the only entries used in the least-squares 
fitting. We denote the diagonal entries of the covariance by the vectors 
 ࢉ෤ெ ൌ diag൫ܥሚெ൯ and cwlc = diag(Cwlc).We model the covariance estimates for M samples by 
 
The ξ denotes a Gaussian with independent components each having mean zero and 
covariance < ξξ T> = DM. The covariance has diagonal entries 
 
with the off-diagonal entries zero. 
 
This model can be used to study how sampling errors from the estimate of the modal 
covariances ࢉ෤ெ propagate into the estimation of the persistence length ሚ݈௣. In particular, from 
the least-squares fit of Eq. 15, we have 
 
This shows the estimated inverse persistence length ሚ݈௣ି ଵ is a Gaussian-distributed quantity 
with mean ߤ෤ ൌ ሚ݈௣ିଵ and variance ߪ෤ெଶ ൌ ࢊ்ܦெࢊ/‖݀‖ସ. 
 
The estimated persistence length ሚ݈௣ has the probability distribution 
 
Note that this distribution is not Gaussian; instead, it has long-tails as a consequence of the 
ሚ݈௣ି ଶ	term and yields an infinite variance. For different values of M, this distribution is shown 
in Fig. S1 in the Supporting Material. 
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The non-Gaussian form of the distribution requires that some care is taken when 
characterizing how the sampling errors influence the estimated value of ሚ݈௣. We can no longer 
make use of the standard deviation to give the magnitude of errors because the second 
moment is infinite. Instead, we use a confidence interval based on the above probability 
distribution ρM. Interestingly, although the second moment is infinite, the distribution ρM can 
be well approximated by a Gaussian distribution for M sufficiently large (M > 100; see Fig. 
S1). Through an asymptotic analysis of Eq. 20, as M becomes large, we find ρM is 
approximated by a Gaussian with mean µ = lp and variance ߪெଶ ൌ ݈௣ସߪ෤ெଶ ൌ ݈௣ସࢊ்ܦெࢊ/‖ࢊ‖ସ. 
This can be used in practice to obtain confidence intervals for errors in estimates of ሚ݈௣. 
 
2. Generating simulated fluorescence images with controlled levels of noise and artifacts 
To investigate effects of image noise on persistence length determination, we develop a 
systematic benchmarking approach, in which we generate an ensemble of simulated images 
from the fluctuations of a simulated biopolymer with known mechanical properties. We 
introduce in these images simulated background noise and other artifacts. 
We then use our contour tracing and spectral analysis methods to determine the persistence 
length. A comparison of the measured and actual persistence lengths provides a well-
controlled test for the reliability of the proposed methods, and enables experimental 
conditions to be optimized to improve measurement precision and accuracy. 
 
To generate noise and artifacts similar to those encountered in experiments, we consider 
primarily two types of noise: 1), background noise in which randomly varying levels of 
intensity are seen throughout the image, and 2), sporadic gaps in which intensity varies in the 
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fluorescence signal along the biopolymer. The background noise is motivated by 
contributions from ambient light sources and out-of-focus fluorophores, whereas gap artifacts 
are motivated by the uneven binding of fluorescent labels along the biopolymer, inherent 
fluorescence excitation inefficiencies, and stochastic photobleaching. 
 
To simulate the configurations of a biopolymer having a specified persistence length, we 
generate modal coefficients for our orthogonal polynomial representation of the contour 
using the multivariate Gaussian distribution with mean zero and covariance given by Eq. 10. 
Throughout our presentation, we use lp = 10 and calculate values for the first eight modes (N 
= 8). To obtain an image with a fluorescence signal for the biopolymer of thickness r0, we 
use the kernel function of Eq. 2 to trace along the biopolymer contour. For convenience, we 
normalize all fluorescence intensity values to lie between zero and one. We have also 
simulated filament contours using a random walk generator, and we find no significant 
differences in algorithm performance, thereby verifying that there is no bias introduced when 
generating the contours by using the Chebyshev basis. 
 
To introduce background noise, we perturb each pixel value using two different Gaussian 
distributions. For pixels that are located on the contour, we perturb by a random value having 
mean µc = 0 and variance σ2 c. For pixels not located on the contour, we perturb using mean 
µb = 0 and variance σ2 b = σ2 c. To characterize the noise, we define Ic to be the characteristic 
intensity difference between the contour and background ܫ௖ ൌ 〈ܫሺݕሻ〉௖ െ 〈ܫሺݕሻ〉௕, where 〈∙〉௟, 
݈	 ∈ ሼܾ, ܿሽ gives, respectively, the average of intensity values over the contour or background 
pixels. To characterize the level of background noise in our images, we use the ratio σb/Ic. 
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To introduce gap noise along the contour, we modulate the fluorescence signal by a weight 
function obtained from a cosine series 
 
The random weight coefficients wk are chosen so that the integral of c(s) over [0,L] has mean 
mg and variance σ2 g. The form of c(s) necessitates that w0 = µg. To achieve a variance 
proportional to σ2 g, we use (w1,…,wK-1) uniformly distributed over the surface of a K-1 
dimensional sphere of radius √2ߪ௚. To control how oscillatory the gap artifacts appear in the 
image, we vary the number of modes K. The random coefficients ensure random amplitude 
and phases for each of the modes, creating an irregular, realistic gap pattern. We find that K = 
25 provides a modulation that agrees well with what is seen in experimental fluorescence 
images. To characterize the level of gap artifacts in our images we use the ratio σc / µg. 
 
3. Benchmarking studies for different levels of noise and artifacts 
To investigate the robustness of our methodology, we numerically generate ensembles of 
fluorescence images with prescribed noise conditions, similar to those observed in 
experiments (see Fig. 3-4). In contrast to prior works that have modeled the role of noise on 
fitting using theoretical assumptions [78], this benchmarking approach provides a direct and 
realistic comparison with actual microscopy data. The ensembles contain M = 1000 images, 
simulating the thermal fluctuations of a biopolymer with persistence length Lp = 9.45 L, 
where L is the polymer length (taken to be ‘‘1’’ in arbitrary units). To minimize the effects of 
sampling errors in these studies, we use the same underlying configurations for the simulated 
biopolymer to generate each ensemble of images. A sample image from each of these 
ensembles is shown in Fig. 3-3. 
53 
 
To initialize the contour tracing routine, an initial contour is chosen as the diagonal of a 
bounding box that encloses the Z brightest pixels (Z is typically chosen to be 2500). Because 
our algorithm is optimized to identify stiff, isolated filaments, the bounding box is 
automatically drawn around the filament of interest. We calculate the average intensity at 
each corner, and choose the diagonal that connects the two brightest corners as our initial 
contour for fitting. This diagonal typically overlays the actual filament, with numerous points 
of intersection and the length of the diagonal is roughly equal to the actual filament length. 
 
To determine the effect of initial conditions on filament tracing, we tested 300 perturbations 
to the best initial fit of a single noisy numerically generated fluorescence image, then 
recorded the maximal difference between the final fit and the actual filament position to 
determine the robustness of our tracking algorithm. For the perturbations, the angle of the 
initial fit was chosen to lie within a range of [-π/8, π/8] around the actual filament position, 
whereas the midpoint was independently perturbed to lie within a circle of radius 20 pixels 
from the actual center. For noise levels, we chose values that were similar to those observed 
experimentally. Of these, 90% of the initial fits converged to within two pixels (maximal 
deviation) of the correct contour, whereas 5% fit a portion of the filament well but failed to 
track the filament ends, and another 5% were drawn in regions dominated by noise and thus 
failed to converge to anything reasonable. This reproducibility demonstrates that our 
steepest-descent algorithm requires only a single point of intersection between the initial 
contour and fluorescence signal of the polymer to reliably trace the polymer shape. 
 
54 
 
Using an unperturbed initial fit, we find that in the absence of any explicitly introduced 
background noise or gap artifacts, our methods yield an estimated nondimensional 
persistence length of ሚ݈௣= 9:38. We use this value (which is well within the expected range 
given our sampling error of 5.2% for M = 1000 images) as our reference when reporting 
relative errors to remove the baseline sampling error from the reported results and better 
reflect the differences in the levels of noise and artifacts in the images. For each simulated 
ensemble of images, we performed the spectral analysis using the initial five Chebyshev 
modes, which, for the stiff filaments we consider here, represent physically meaningful 
fluctuations. We report the results of the spectral analysis using our methods for each of the 
image ensembles in Table 2-1. When performing fits, we find that introduction of noise and 
gap artifacts can, in a small number of cases, result in images of insufficient quality. For such 
images (typically <5% of the ensemble), the contour fitting does not converge in a manner 
that is independent of the initial trial contour. These images are ignored when estimating the 
modal covariances and persistence length. In the case of experimental data, there is an initial 
manual review of images to eliminate those which show significant blurring of the filament 
contour or the presence of a very large interfering object. Additionally, we use only those 
mode variances that lie within ≈ 3 standard deviations of the mean, to eliminate the 
possibility that a rare fitting artifact could disproportionately change our stiffness results. In 
practice, very few images (<10%) are rejected based on these criteria.  
As shown in Table 2-1, our global fitting approach enables robust determination of 
persistence length, even in the presence of substantial background noise and gap artifacts, 
which are frequently encountered in experiments. We find relative errors for the estimated 
persistence length to be <1% for a majority of low-to-moderate noise cases, and <10% even 
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for the largest background and gap noise levels probed. We find similarly good agreement 
for simulated filaments that are an order-of-magnitude stiffer and tested using an even larger 
range of gap and background noise conditions and sample sizes (see Table S3 in the 
Supporting Material). 
 
To further demonstrate the level of improvement in filament tracing and persistence length 
determination in comparison to more conventional approaches, we generated and analyzed 
ensembles of 500 images of filaments with known stiffness, and subjected them to known 
noise-background and gap-noise artifacts. To assess the quality of contour fitting, we used 
two methods: the global contour tracing routines described above, and a pointwise fitting 
routine in which the filament position was determined by fitting a Gaussian distribution to 
the cross-sectional intensity profile of the filament at 200 points along the contour. We 
compared the coordinates outputted from each fit routine (xfit, yfit) to the coordinates used to 
generate the filaments (xo, yo) and calculated the root mean square (rms) error at each pixel 
position to be 
 
For both fitting methods, we found the mean value of Erms to be <1 pixel; however, we find 
the fit errors to be substantially lower when using our global fitting routine (as shown in 
Table S1). We see a factor-of-2 improvement in contour fitting under low noise conditions, 
and a 10–20% improvement in even the noisiest cases. To complete the comparison, we then 
input the filament coordinates determined via pointwise fitting into a Fourier-based spectral 
analysis routine. We found reasonable agreement with the known persistence length (<10% 
deviation) for all noise levels when using only the first Fourier mode. However, we found the 
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higher modes to be unreliable, particularly under levels of high background and gap noise 
(see Table S2). Noise corruption in the higher modes limits the use of averaging to improve 
measurement accuracy and prevents the identification of deviations from WLC behavior. The 
ability to average the response of the higher-order modes, each of which fluctuates 
independently, is particularly important, as sampling error dominates measurement 
uncertainty in many cases.  
 
4. Experimental results for microtubules 
To demonstrate our approach in practice, we apply our filament tracing and spectral analysis 
methods to characterize the persistence length of an isolated microtubule (MT) imaged using 
total internal reflection fluorescence microscopy. The MT was labeled with rhodamine dyes 
to enable visualization, and confined to move within a thin, well-sealed sample chamber to 
ensure that the fluctuating filament remained in focus throughout the experiment and only 
thermal forces acted upon the MT. The MTs were polymerized in the presence of the 
stabilizing compound taxol, rendering their length constant over the time course of the 
measurement, which is typically limited by fluorophore bleaching to be <100 s. The 
experimental details are further described in the Supporting Material. 
 
MTs were visualized using an electron-multiplying charge-coupled device camera in full 
frame transfer mode at a frame rate of 10 Hz and using an exposure time of 0.1 s, which is 
comparable to the relaxation time of the slowest hydrodynamic mode. To verify that filament 
motion during this exposure time was not influencing our measurement, we reduced the 
exposure time to 0.066 s or 0.033 s (at a fixed frame rate of 10 Hz), and found no obvious 
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trend in our persistence length data that would indicate a systematic bias. We did, however, 
find that image noise increased substantially for shorter exposure times, with an ~40% 
increase in background noise for the 0.033-s exposure time as compared to the 0.1-s exposure 
time. A smaller fraction of images have convergent fits under these high noise conditions, 
consistent with the benchmarking results shown in Table 2-1. 
 
As a test of our approach, an ensemble of M = 147 fluorescence microscopy images was 
analyzed using our contour fitting method and least-squares estimator to analyze the first four 
modes. From these, we determine a nondimensional persistence length of ሚ݈௣ = 176.6 using 
the spectral characteristics of the fluctuating filament (see Fig. 3-4). In this test case, the MT 
contour length was estimated to be ܮ෨ = 19.6 µm. This gives an actual dimensional persistence 
length of ܮ෨௣ = 3.45 mm. To determine the uncertainty in this measurement, we consider 
errors arising from both sampling and image artifacts.We estimate the sampling error when 
using only M = 147 images to be ±0.48 mm in ܮ෨௣. From analysis of the experimental 
fluorescence images, we estimate an average effective background noise of σb/Ic = 0.143 and 
average effective gap noise of σg/µg = 0.184. From the results of a benchmarking study 
performed under similar noise conditions, we estimate the contribution to ܮ෨௣-uncertainty to 
be ±0.2 mm. We anticipate that the uncertainties due to sampling errors and noise artifacts 
behave in a fairly independent manner. Under this assumption, the total uncertainty can be 
estimated by adding these two contributions in quadrature. Therefore, we estimate ܮ෨௣ = 3.45 
± 0.52mm.These results represent a measurement uncertainty of ≈ 15%. Our measured 
persistence length is well within the range of previously reported values [81, 90]. The dashed 
black line in Fig. 3-4 shows the variances for the Chebyshev modes predicted using a WLC 
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model with the same mean bending stiffness. Although deviations from WLC behavior have 
been reported for short MTs, for the range of MT lengths (≈ 8–20 µm) reported here, we find 
the predicted good agreement between the WLC model and our spectral data, for at least six 
independent modes [98]. This validates our fitting algorithm under experimental conditions 
and relatively small sample sizes. 
 
We then applied this method to the study of an ensemble of 54 different MTs, generated 
under chemically identical conditions, and subjected to identical temperature, storage, and 
handling conditions. For each MT, ~300 images were analyzed to determine the single-
filament persistence length. Given the image noise and sampling errors, we would predict a 
measurement uncertainty of ≈ 10%. As shown in Fig. 3-5, we measure a much larger range 
of persistence lengths, indicating that real sample heterogeneity, not image processing 
uncertainty, is driving this broad distribution. Within this large variation, we find the 
persistence length to be independent of the filament length, for the range of lengths (10–20 
µm) studied here (see Fig. S2). 
 
In the limit of homogeneous isotropic materials at fixed ambient temperature, the persistence 
length depends only on the Young’s modulus E, contour length L, and filament radius, r. Lp 
varies linearly with E, which has been found to be in the range of 2-3 GPa for a wide range 
of proteins, including tubulin and actin, likely due to van der Waals interactions along the 
protein backbone [99]. By contrast, Lp varies as r4, indicating that even small polydispersity 
in MT radius could give rise to substantial variations in stiffness. Interestingly, MTs have 
been shown to form with variable numbers of protofilaments both in vivo and in the presence 
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of taxol in reconstituted systems [42]. Thus, we favor a model in which an ensemble of MTs 
with differing radii give rise to a broad distribution of MT persistence lengths. A less likely 
possibility, in our view, is that the assumption of homogeneity and isotropy fails under some 
conditions, in which case it is more difficult to relate changes in Lp to a molecular 
mechanism. We would expect that in this limit, the fluctuation spectra would not follow a 
WLC model, so we would argue that the assumption of homogeneity and isotropy is 
appropriate in our analysis. 
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Table 2-1: Results for the simulated ensembles of fluorescence images 
 
To test the robustness of our spectral analysis methods, we simulated ensembles of 
fluorescence images with varying levels of background noise and gap artifacts generated 
from the fluctuations of a simulated biopolymer with known persistence length, Lp = 9.45 L, 
where L is the polymer length (taken to be ‘‘1’’ in arbitrary units). At each condition we use 
M = 1000 simulated images. To simulate the configurations of a biopolymer having a 
specified persistence length, for each image we generate modal coefficients for our 
orthogonal polynomial representation of the contour using the multivariate Gaussian 
distribution with mean zero and covariance given by Eq. 10. We calculate values for the first 
eight Chebyshev modes (N = 8). We report the relative errors (% Err) in these estimates and 
the percentage of images found to be of sufficient quality to allow for convergent fits 
independent of the initial trial contour (% Conv). Relative errors are reported with respect to 
the baseline case of no background noise or gap artifacts. The table indices correspond to the 
same ordering and ratios used for characterizing the ensembles of images shown in Fig. 3-3. 
 
 
 
 
Figure 3-3: Ensembles of simulated fluorescence images. To investigate our spectral 
analysis methods when subjected to the types of noise and artifacts found in experimental 
images, we simulate ensembles of images from a simulated biopolymer with known 
mechanical properties. Shown here are images generated from biopolymer configurations 
using our contour representation with lp = 10, N = 8. The ensembles correspond to different 
levels of background noise throughout the image and gap artifacts along the biopolymer 
contour. The background noise increases left to right while the gap artifacts increase from top 
to bottom. The level of background noise is characterized by the ratio σb/Ic for the perturbed 
background pixel standard deviation σb and the average difference of intensity between the 
contour and background Ic. The level of gap artifacts is characterized by the ratio σg/µg 
obtained by integrating the random cosine modulations used to generate the artifacts to 
obtain an effective mean mg and standard deviation σg. 
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Figure 3-4:  Experimental results for a microtubule. We analyze, using our spectral analysis 
methods, the thermal fluctuations of a microtubule for M = 147 images. (Inset) Exhibited 
thermal fluctuations in the microtubule shape. The exhibited modal covariances of the 
microtubule fluctuations agree well with a WLC model (dashed line). The error bars 
correspond to the 95.5% confidence intervals using our sampling error analysis in Role of 
Sampling Error on Estimated Persistence Length (see main text). Our methods yield an actual 
dimensional persistence length of ܮ෨௣ = 3.45 ± 0.52 mm. 
 
 
Figure 3-5: Experimental results for an ensemble of microtubules. Histogram of the 
persistence lengths of an ensemble of 54 different MTs, generated under chemically identical 
conditions, and subjected to identical temperature, storage, and handling conditions. For each 
MT, ~300 images were analyzed to determine the single-filament persistence length. Given 
the image noise and sampling errors, we would predict a measurement uncertainty of ≈ 10%, 
yet we measure a much larger range of persistence lengths, indicating that real sample 
heterogeneity, not image processing uncertainty, is driving this broad distribution. 
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D. Summary 
We present what to our knowledge are new spectral analysis methods for the measurement of 
biopolymer flexural rigidity from observations of the biopolymer thermal fluctuations. Our 
approach was based on global fitting of an entire trial contour at once to the fluorescence 
image. We used a contour representation expressed in terms of the curve tangent angles 
parameterized by arc-length and expanded in a basis of orthogonal polynomials. Using this 
representation, we performed statistical analysis of the modal coefficients to infer a flexural 
rigidity for the biopolymer. Our spectral analysis methods were found to work very well even 
in the case of images exhibiting significant background noise and gap artifacts. The 
benchmarking approach we propose provides a potentially powerful metric for rating 
different spectral analysis methods and for understanding the statistical significance of 
differences reported in experimental results. Our data indicate that these spectral analysis 
methods provide a substantial improvement in precision for measurements of stiffness based 
on observed fluctuations of a biopolymer. We expect these approaches will enable future 
studies of the differential effects of polymerization conditions and the binding of various 
regulatory molecules on microtubule mechanics. 
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IV. Mechanical and Functional Properties of Epothilone-stabilized 
Microtubules3 
This work was published in Cytoskeleton in 2013 [100]. All information in this chapter and 
additional supplemented materials can be found on publisher’s website. 
 
This section will discuss the effect of the MT stabilizing drugs epothilone-A and epothilone-
B on both the mechanics of microtubules and functional transport properties of kinesins 
moving on these microtubules.  
  
A. Abstract 
Using a suite of biophysical tools, we assess the mechanical, structural, and functional 
properties of microtubules stabilized by the chemotherapeutic compounds epothilone-A, 
epothilone-B, and taxol in vitro. We demonstrate that microtubules stabilized by epothilone-
A or epothilone-B are competent to bind tau proteins, and support kinesin translocation. 
Kinesin speed is sensitive not only to the type of small molecule stabilizer used, but also to 
the presence of the essential microtubule-associated protein tau. Epothilone-stabilized 
microtubules are substantially less stiff than taxol-stabilized microtubules. The addition of 
tau proteins to microtubules stabilized by either epothilone compound or taxol further 
reduces stiffness. Taken together, these results suggest that small molecule stabilizers do not 
simply stabilize a ‘native’ microtubule structure, but rather they modulate the structure, 
function, and mechanics of the microtubules they bind. This may have important 
consequences to the therapeutic use of these agents in cancer chemotherapies. 
                                                 
3 Reprinted from Cytoskeleton 70 (2), Yu, et al., Mechanical and functional properties of epothilone‐stabilized 
microtubules, 74-84, Copyright (2013), with permission from John Wiley and Sons. 
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B. Introduction 
Taxanes and epothilones are potent chemotherapeutic drugs that target a broad spectrum of 
solid mass tumors by inhibiting microtubule (MT) dynamics, arresting mitosis, and inducing 
cell death [101-103]. Although these compounds are effective in reducing tumor size and 
improving survival rates, they can generate disabling and dose-limiting neuropathic side-
effects, including pain and loss of sensation, which limit their clinical use [104-107]. The 
molecular basis of these effects is poorly understood, and as a result there are no approved 
therapies for the prevention or mitigation of chemotherapy-induced peripheral neuropathy 
(CIPN) [107, 108]. Onset of symptoms not only reduces quality of life, but impacts health 
and survival due to treatment delays and discontinuations. Interestingly, axonal dysfunction 
has been observed within the first month of treatment, well before the typical onset of pain 
symptoms [109]. This raises the possibility that MT-based kinesin transport and/or the MTs 
themselves may be altered by the stabilizing compounds, and more importantly, suggests that 
early or prophylactic interventions might be possible, if quantitative, predictive models of the 
molecular mechanisms of CIPN were known.  
 
Although taxol-stabilized MTs have been used extensively in in vitro measurements of 
microtubule stiffness and kinesin-based motility, there have been very few reports of the 
effects of other anti-cancer therapeutics [7, 34, 78, 80, 110]. To address this, we use in vitro 
assays to directly measure the stiffness of, and the rates and patterns of collective kinesin 
translocation along, MTs that have been assembled by a variety of small molecule stabilizers 
and coated with the essential MT-associated protein (MAP) tau [9, 59]. 
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Tau is a neural MAP that binds to MTs, promotes tubulin polymerization, regulates MT 
dynamics, and is essential for the normal development and maintenance of the nervous 
system [8, 26-29, 111-117]. Through alternative RNA splicing, a single tau gene produces 
six different tau isoforms, each of which possesses either three or four imperfect repeats in 
the C-terminal half of the protein (‘3R tau’ or ‘4R tau’), separated from one another by 
shorter inter-repeats [21, 23, 35]. In addition, each tau isoform possesses either zero, one or 
two inserts in the N-terminal portion of the protein [21, 23, 38, 41]. 
In this study, we focus on the ‘short’ tau isoforms with zero N-terminal inserts (referred to 
simply as ‘3R’ or ‘4R’ herein), which are abundantly expressed in neurons, and have strong 
MT binding and regulatory activities [7, 34]. We demonstrate that MTs stabilized by 
epothilone compounds bind tau proteins with affinities that are similar to those of taxol 
stabilized MTs. However, we find that epothilone-stabilized MTs are softer than taxol-
stabilized MTs, and that they support slower rates of kinesin translocation when cargos are 
moved in the presence of tau. 
 
C. Materials and Methods 
1. Tubulin preparation and microtubule assembly  
MAP-free tubulin dimers (>99% pure) were purified from bovine brain without stabilizing 
agents as previously described [51]. Briefly, tubulin was purified from brain homogenates by 
two cycles of polymerization and depolymerization, followed by elution through a 
phosphocellulose column. Rhodamine-labeled tubulin (0.14 mole rhodamine per mole 
tubulin) was prepared as described [52]. MTs were prepared by mixing 20 M of MAP-free 
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tubulin and rhodamine-labeled tubulin mixed at a molar ratio of 5:1, with taxol, epothilone-A 
or epothilone-B (Sigma Aldrich) in PEM80 buffer (80 mM PIPES, 1 mM EGTA, 4 mM 
MgCl2, pH 6.9) supplemented with -mercaptoethanol and 2 mM of GTP. MTs were 
assembled at 35° C with an initial 10 minute incubation, then epothilone-A, epothilone-B, or 
taxol was introduced in 3-steps, to a concentration of 1 µM, then 6.5 µM, then 20 µM (final) 
with 20 minute waiting periods between each addition (total reaction time is 70 minutes). 
This step-wise addition is commonly used when generating taxol-assembled MTs to prevent 
formation of non-MT structures and promote long MTs [56]. The total tubulin concentration 
in the resulting stock MT solution is 20 M. 
 
2. Protein Expression and Purification 
The kinesin construct (K560-CL-his) was a gift from Dr. Ron Vale (UCSF). In a pET 
expression vector, the cDNA encodes the N-terminal 560 amino acids of human conventional 
kinesin heavy-chain that lacks solvent exposed cysteines but retains normal enzymatic and 
motile properties [54]. A C-terminal hexa-histadine cluster allows for Ni-affinity purification. 
K560-CL-his was expressed in BL21 (DE3) cells (Invitrogen), and purified as previously 
described [50]. When prepared for use with quantum dots, the purified kinesin proteins were 
subsequently labeled with EZ-Link® Maleimide-PEG2-Biotin (Thermo Scientific) via 
maleimide-thiol coupling. In both cases, kinesin was concentrated, supplemented with 10% 
sucrose and 0.1 mM ATP, drop frozen in liquid nitrogen in single-use aliquots and stored at -
80°C. 
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Tau-encoding plasmids and expressed proteins were a gift of Dr. Stuart Feinstein, UCSB. 
Tau (>99% pure) was recombinantly produced using pRK expression vectors containing 
cDNA sequences encoding 3-repeat or 4-repeat human tau containing no N-terminal inserts 
(which we refer to as 3R or 4R tau herein). Recombinant tau was purified as previously 
described except that the final purification steps consisted of a HiTrap Phenyl HP column 
(GE Healthcare) followed by dialysis into BRB-80 buffer (80mM PIPES, 1 mM EGTA, 1 
mM MgSO4, pH 6.8) supplemented with 0.1% β-mercaptoethanol [53]. The concentration of 
purified tau was determined by quantitative SDS-PAGE, through comparison with a tau mass 
standard [43]. 
 
3. Tau-MT Cosedimentation Assays  
Cosedimentation assays were used to determine the amount of bound tau under each 
polymerization condition. Here, MTs were formed as described. 3R or 4R tau were added at 
a molar ratio of 5:1 or 30:1 tubulin dimer:tau, and the reaction allowed to continue for an 
additional 15 minutes at room temperature. In detail, we used 3 μM and 0.5 μM of tau, and 
added the appropriate amount of MTs based on the tau:tubulin ratio. Tau-coated MTs were 
layered over 180 μL of a warm sucrose cushion (50% w/v in PEM-80, supplemented with 
2mM GTP) in a 5×20 mm UltraClear centrifuge tube (Beckman Coulter). Samples were spun 
in a TLA 100.3 fixed angle rotor for 12 min at 60,000 rpm (194,000×g) at 35°C. 
Supernatants and pellets were collected and solubilized in SDS-PAGE sample buffer. The 
quantities of tau and tubulin in each were determined by Western blotting using the 
monoclonal antibody Tau-1 (Millipore) and Coomassie blue staining respectively, taking 
care to operate within the linear detection range. Negligible quantities of tau or tubulin 
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remained within the cushion. These data were used to determine the molar ratio of tubulin to 
tau in the MT pellet. 
4. Kinesin-driven MT Gliding Assays 
Gliding assays were performed as previously described, with minor modifications [50]. 
Flow-chambers were constructed by attaching a coverslip to a glass slide with double-sided 
tape. Prior to use, coverslips were cleaned by exposure to a gas plasma generated by 
exposing room air to an 18 W radio-frequency oscillating field for 10 minutes at pressure of 
~0.5–2 Torr using a commercial benchtop plasma cleaner (Harrick PDC-32G). Kinesin was 
diluted to 20-50 µg/ml in PEM80 buffer containing 10 mM β-mercaptoethanol then flowed 
into the chamber and allowed to directly adhere to the glass surface for 3 min. Following 
attachment of motors, the chamber was incubated for an additional 5 min with a solution of 
casein (~0.5 mg/mL) to reduce the non-specific binding of MTs to the glass surfaces. 
Microtubules were polymerized as described and used within 24 hours. For experiments with 
tau protein, 3R or 4R tau was added to a final ratio of 5:1 tubulin to tau. For measurements 
without tau protein, an equivalent volume of warm buffer was added to ensure similar final 
MT concentrations. In all cases, the MTs were incubated at 35°C for another 15 minutes, and 
the solution was diluted 1:100 in warm motility buffer containing PEM80, 5 mM ATP, 0.1% 
β-mercaptoethanol and an enzymatic oxygen scavenger system (650 U/mL catalase, 15 
U/mL glucose oxidase and 4.5 mg/mL glucose, final concentrations). The diluted MTs were 
flowed into the kinesin-containing flow chamber, which was sealed with vacuum grease and 
visualized immediately. Gliding events were visualized using a Nikon Ti-S microscope 
equipped with custom-built total internal reflection fluorescence (TIRF) illumination 
capabilities (100ä magnification, 67 nm/pixel, 19-20°C ambient temperature). Excitation 
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wavelength used for rhodamine imaging was 532 nm. Images were collected using an air-
cooled EMCCD camera (Andor, iXon) every 0.4 s for 100 frames. MT tracking was 
performed manually using ImageJ to identify the leading tip of the moving MT in each 
frame. To calculate velocity, the total MT trajectory was divided by the time interval over 
which motion was observed. 
 
5. Kinesin-driven Quantum-Dot (QD) Assays 
The epothilone-stabilized MTs used in the QD assays were generated as described with an 
extra centrifugation step (14 krpm, 10 minutes) to remove unpolymerized tubulin dimers, 
which contribute to background fluorescence. The pellet was gently resuspended in a 
stabilization buffer containing 1 mM GTP, 2 µM epothilone-A or epothilone-B, 1 mM DTT 
and 2 g of sodium azide in PEM 80, and stored at room temperature, away from light. MTs 
formed by this method are typically stable for up to one week. QD assays were performed as 
previously described, with modifications [57]. Glass flow chambers were constructed by 
attaching plasma cleaned 22×40 mm #1.5 coverslips to clean glass microscope slides with 
two parallel pieces of double-sided tape spaced ~5 mm apart. β tubulin antibody (SC-58884, 
Santa Cruz Biotechnology Inc.) solution (40 μg/mL) was flowed into the chambers to allow 
absorption to the coverslip surface. After 10 min, excess antibodies were washed out by 
addition of 50 μL of PEM 80. The stock MT solution was diluted 1:20 in PEM 80, and 20 μL 
of diluted MT solution was flowed into the chambers. After a 10 min incubation period, 4 
mg/mL casein solution was introduced to remove the unattached MTs, and to passivate the 
glass surfaces against non-specific adsorption of kinesin or tau. After 10 min, biotinylated 
kinesins, diluted to ~20 ng/mL in a solution of PEM80 supplemented with 1 mM AMPPNP, 
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were introduced to the flow chamber. After 5 min, chambers were washed and Qdot® 605 
steptavidin conjugated quantum dots (Q10101 MP, Invitrogen), diluted in 0.2 nM in PEM 80 
were introduced. After another 5 min, chambers were washed with a standard motility buffer 
for single-molecule kinesin measurements, consisting of PEM80 supplemented with 5 mM 
DTT, 1% -mercaptoethanol, an enzymatic oxygen scavenger system (650 U/mL catalase, 15 
U/mL glucose oxidase and 4.5 mg/mL glucose, final concentrations), 1 mM ATP, and the 
desired type of tau protein at a final concentration of 100 nM tau. The chambers were sealed 
with vacuum grease and visualized immediately at room temperature (19-20°C). Under these 
assembly conditions, the polymerized tubulin dimer to kinesin dimer molar ratio in the 
microchamber is approximately 25:1. Considering the cylindrical geometry of the 
microtubule and the size of the QD there will be, on average, 2-3 microtubule-bound kinesin 
molecules accessible to any QD that diffuses near a microtubule. 
 
Motions of single QDs were visualized using a custom-built TIRF microscope at 150ä 
(magnification = 67 nm/pixel). Images were collected at room temperature using air-cooled 
EMCCD camera (Andor, iXon) at a rate of 10 frames per second. Excitation wavelength for 
QD imaging was 488 nm. A broadband emission filter was selected to allow the dim outline 
of the rhodamine-labeled MT to be observed in the background of the bright QD images. 
Images were analyzed off-line after data collection. Movies were manually screened to 
identify the motion of kinesin-driven QDs that warranted velocity analysis. Only runs that 
persisted for at least 30 frames were analyzed. QD position was determined as a function of 
time using the built-in FIONA algorithm available through Video Spot Tracker software 
(made available by CISMM at UNC-CH, supported by the NIH NIBIB, Award# NIH 5-P41-
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RR02170). The initial velocities of the kinesin-QD assemblies were calculated framewise 
then refined to discriminate between motions parallel or perpendicular to the MT axis using a 
graphic-based analysis algorithm implemented in MATLAB. This was particularly useful for 
cases in which tau binding disrupted the antibody-MT connection, leading to thermal 
fluctuations of the MT substrate upon which the kinesin motors walk. For each moving 
kinesin-QD assembly, a region with a width of 15 pixels was drawn around the average 
location of the underlying MT track. The MT location was then determined by fitting a 
Gaussian curve to the cross section of intensity of the MT contour using ~ 100 evenly 
distributed points, as previously described [59]. Curve fitting was implemented using built-in 
algorithms. Using the resulting MT coordinates, the initial velocities were projected into two 
orthogonal components, one parallel and one perpendicular to the MT contour. The kinesin 
velocity for a single translocation event (i.e., a 'run') was given by the mean of the parallel 
components of the framewise velocities. 
 
6. Microtubule Fluctuation Assays  
Epothilone-assembled MTs were diluted into a PEM 80 based solution supplemented with 5 
mM DTT, 1% β-mercaptoethanol with oxygen scavenger system (glucose oxidase, catalase, 
glucose) and 1-5 mg/ml casein. For experiments with taxol-assembled MTs, the solution is 
supplemented with 10 µM taxol. A drop of 2.6 µL of the MT solution is pipetted onto a clean 
glass slide, and a plasma-cleaned 22ä40mm #1.5 cover glass is placed on top. Gentle 
pressure is applied to spread the solution over the entire surface of the cover glass, resulting a 
distance between the glass surfaces of ~3 µm. The chamber is sealed with VALAP wax 
(equal parts vaseline, lanolin, and paraffin) to prevent convection and evaporation. The 
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sample is observed immediately using the custom-built TIRF microscope and images 
collected using an air cooled EMCCD camera at a rate of 10 frames per second. For these 
measurements, we set the incident angle for laser injection to be slightly below the critical 
angle for true total internal reflection. This allows a mixed mode TIRF/epi excitation that 
allows visualization of the filaments throughout the depth of the observation chamber. 
Magnification is 67 nm/pixel, and data are collected at room temperature (19-20°C). A movie 
of 300-400 frames was collected for each fluctuating MT, and was analyzed using a custom-
designed tracing and spectral analysis method, as described [59].  
 
D. Results  
1. Cosedimentation assays assess ability of MTs to bind tau 
To assess the ability of epothilone-stabilized MTs to bind wild-type (WT) tau isoforms, we 
performed cosedimentation assays in which MTs are assembled in the presence of either 
epothilone-A or epothilone-B, then coated with tau. We used a total tubulin dimer to tau 
molar ratio of 5:1 or 30:1, which brackets the approximate physiological range for 
neurons [60, 61]. Previous results have demonstrated that tau binds to MTs in the absence of 
stabilizing agents and to taxol-stabilized MTs with a high affinity in this concentration 
range [9, 50].  
 
We find no obvious differences between the abilities of microtubules stabilized with 
epothilone-A or epothilone-B to bind either tau isoforms, as shown in Figure 4-1. To assess 
the statistical significance of these data, we use a two-sample Student’s t-test, we find that 
the ratios of polymerized tubulin dimers to bound tau are indistinguishable under these 
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conditions (full results of statistical tests are available in Table I). Consistent with prior 
results, we find that the ratio of tubulin in the MT polymer to bound tau  is smaller than the 
ratio of free tubulin to tau  in the initial mixture, since not all tubulin dimers are incorporated 
into the polymer (especially at higher tubulin:tau molar ratios) and tau binds strongly to MTs 
but not tubulin subunits [50].  
 
We then compared the tau binding behavior of the epothilone-stabilized MTs to that of MTs 
stabilized with taxol. Qualitatively, we find that MTs stabilized with taxol appear to bind 
slightly more tau than do MTs stabilized with either epothilone compound, as shown in 
Figure 4-1. Using a two sample Student’s t-test, we find that the differences between MTs 
stabilized with epothilone-A and taxol are not significant to the 95% confidence level under 
any tau condition. For MTs stabilized with epothilone-B, there are significant differences for 
4R tau at both the 5:1 and 30:1 tubulin:tau ratio, and for 3R tau at the 30:1 tubulin:tau ratio. 
For both the taxol- and epothilone-stabilized MTs, we find a reduction in the amount of 
bound tau as compared to MTs that have been polymerized in the presence of tau but without 
small-molecule stabilizers. This reduction is significant for all taxol-stabilized MTs, and for 
all epothilone-stabilized MTs at the 30:1 tubulin:tau ratio. At the 5:1 tubulin:tau ratio, only 
the 4R binding to epothilone-B-stabilized MTs was statistically different from the binding of 
4R to MTs in the absence of small molecule drugs. This suggests that in the absence of 
stabilizers, MTs adopt different conformations that modulate the tau binding affinity, or that 
some fraction of the tau proteins are incorporated on the inner surface of the MT that is not 
easily accessible after polymerization, or both. 
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At the 30:1 tubulin:tau ratios, less tau is present in the initial mixture, and it is likely that 
differences in the amount of bound tau arise from actual differences in binding affinity since 
there is ample space on the MT for tau to bind. By contrast, at the 5:1 tubulin:tau ratio, 
packing considerations on the MT surface become more important. In this limit of high tau 
concentration, we find fewer differences between the various polymerization conditions, 
suggesting that filament geometry begins to dominate in this regime. 
 
2. Effects of small-molecule stabilizers and tau on MT stiffness 
We next assessed the mechanical properties of epothilone-stabilized MTs using a spectral 
analysis method that allows the stiffness of a freely diffusing filament to be determined from 
the ensemble of shapes it adopts under thermal excitation [78].  In this approach, movies of 
fluctuating rhodamine-labeled microtubules are collected, and the microtubule shape is fit in 
each frame to a continuous curve described by a series of Chebyshev polynomials [59]. The 
variance of the mode amplitudes is then compared to predictions made by the worm-like 
chain (WLC) polymer model to determine the persistence length, Lp, a common measure of 
biopolymer stiffness. Physically, Lp is the length over which the filament tangent angle 
becomes decorrelated. Lp depends both on filament shape and intrinsic materials properties: 
Lp=EI/kBT where EI is the flexural rigidity and kBT is the thermal energy. For isotropic 
homogeneous structures, EI is the product of the Young’s modulus E and the geometric 
moment of inertia I. Although deviations from WLC behavior have been observed for short 
microtubules  (< 7 µm), the microtubules used in our study range from 10–20 m, 
significantly longer than this cutoff [118]. 
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Consistent with prior studies, we find the overall distribution of MT stiffness to be broad and 
non-Gaussian, so we characterize the filament stiffness at each condition by the median 
value, and indicate the percentile differences in the distributions using a box and whiskers 
plot format [119]. As shown in Figure 4-2, in the absence of tau we find MTs stabilized by 
epothilone compounds are substantially softer than are MTs stabilized by taxol. The median 
Lp value for taxol-stabilized MTs is 2.0 mm, whereas MTs stabilized by epothilone-A or 
epothilone-B have median Lp values of 1.6 mm and 1.2 mm, respectively. For MTs stabilized 
by taxol or epothilone-A, the addition of either 3R or 4R tau at a 5:1 molar ratio of 
tubulin:tau softens the filaments. The median persistence length of epothilone-A-stabilized 
MTs drops to 1.0 mm for 3R tau (~ 37% reduction) and 1.1 mm for 4R tau (~ 31% 
reduction). The median persistence length of taxol-stabilized MTs drops to 1.1 mm for 3R 
tau (~ 45% reduction) and 1.3 mm for 4R tau (~ 35% reduction). By contrast, for epothilone-
B-stabilized MTs, the addition of tau has little effect: the median Lp of the epothilone-B-
stabilized MTs increases slightly to 1.3 mm for 3R tau and decreases to 1.1 mm for 4R tau 
(~ 8% increase or reduction, respectively). Interestingly, although we find the stiffness of the 
bare MTs varies substantially depending on the type of small molecule used, upon addition 
of either 3R or 4R tau, these differences nearly vanish.   
 
3. Effects of small-molecule stabilizers and tau on kinesin translocation 
We next assessed the ability of MTs stabilized with epothilone-A or epothilone-B to support 
kinesin motility, and further, tested the effects of 3R or 4R tau proteins on kinesin 
translocation for each polymerization condition. These measurements are motivated by a 
desire to determine the functionality of epothilone-stabilized MTs, particularly with regard to 
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axonal transport, since transport defects have been linked to CIPN. We employ a quantum-
dot (QD)-based motility assay, in which small numbers of kinesin motors are bound to 
fluorescent QDs in a manner that mimics in vivo cargo-attachment. Given the system 
geometry and kinesin concentrations, we estimate that there will be, on average, 2–3 
microtubule-bound kinesin molecules per QD.  
 
We measured the velocity of the kinesin-QD complexes moving on MTs assembled with 
epothilone-A, epothilone-B, or taxol, then coated with no tau, 100 nM 3R tau, or 100 nM 4R 
tau. In the absence of tau proteins, we find no significant difference between the speed of 
kinesin motors moving on MTs stabilized by taxol or epothilone-A; kinesins moving on 
epothilone-B-stabilized MTs show a modest, but statistically significant slowing with respect 
to the taxol MTs (Figure 4-3). The differences between the speeds of kinesins moving on 
MTs polymerized with epothilone-A or epothilone-B are not significant at the 95% 
confidence level. Full statistical analysis of the velocity data is given in Table II.  
 
We find a substantial slowing when we introduce tau. As we previously reported, the 
addition of either 3R or 4R tau to taxol-stabilized MTs reduces the mean kinesin speed from 
425 ± 10 nm/s (errors given by SEM) to 360 ± 15 nm/s (~15% reduction) or 334 ± 20 (~ 21% 
reduction), respectively [9]. For both isoforms, the tau-dependent velocity reduction is 
significant (p < 0.001), whereas the differences in mean speed between the two isoforms (3R 
versus 4R) is not. 
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We also find significant tau-dependent reductions in kinesin speed when using MTs 
polymerized with either epothilone-A or epothilone-B, and moreover find that the magnitude 
of the reduction is significantly larger than that observed when using taxol-stabilized MTs. 
When using epothilone-A-stabilized MTs, the addition of 3R reduces the mean kinesin speed 
from 387 ± 17 nm/s to 218 ± 17 nm/s (~ 44% reduction) and the addition of 4R tau reduces 
the mean kinesin speed to 203 ± 17 nm/s (~ 48% reduction). When using epothilone-B-
stabilized MTs, the addition of 3R reduces the mean kinesin speed from 362 ± 20 nm/s to 
204 ± 17 nm/s (~ 44% reduction) and the addition of 4R tau reduces the mean kinesin speed 
to 208 ± 18 nm/s (~ 43% reduction). For MTs stabilized with either epothilone compound, 
reductions in velocity upon addition of either tau isoform are significant (p < 0.001). 
However, we do not find any significant epothilone compound-specific differences when the 
tau type and concentration is fixed, and we do not find tau-isoform specific differences when 
either epothilone-A or -B are used.  
 
Another common measure of kinesin function in single molecule in vitro assays is the total 
travel distance per diffusional encounter with the MT, or ‘run length’. By contrast, in our 
assay, each QD accommodates a small number of kinesin motors, and thus the cargo run 
length is not a particularly useful metric. In the limit that each motor operates independently, 
the probability of detachment of cargo from the MT depends on the product of detachment 
probabilities of each motor. In the case of single kinesin motors moving along bare taxol-
stabilized MTs, the probability of detachment is ~10-2 per step. Given an 8-nm step size, this 
leads to an average run length of ~ 800 nm. When two motors are simultaneously engaged, 
the predicted run length increases to 80 m, much longer than the average microtubule length 
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used in our studies. Consistent with this, in the absence of tau, >90% of the kinesin-QD 
assemblies bind and translocate to the end of MTs assembled by either epothilone compound 
or taxol. The observed run length is given by one-half of the average MT length and this is a 
substantial underestimate of the actual run length of the assembly. In the presence of tau, the 
percentage of kinesin-QD assemblies that bind and move to the end of the MT drops to 
~50%, and the mean value of run length also decreases, but we do not find any obvious trend 
with type of stabilizing compound used (data not shown). 
 
To confirm the results of our QD assay in a different experimental geometry, we repeated 
these measurements using MT gliding assays, in which fluorescently-labeled MTs glide on 
top of a densely kinesin-coated surface. Multiple kinesin motors bind along the length of the 
filament and each steps toward the MT plus end, thereby propelling the MT across the 
surface. The velocity measured from the gliding assays will thus be an average velocity 
driven by the collective behavior of all active motors. As shown in Figure 4-3 and Table II, 
the data obtained with the gliding assay format follow the same overall trends as those 
obtained with the QD assay. In the absence of tau, we find no significant differences in MT 
velocity when epothilone-A, epothilone-B, or taxol are used. We find a significant velocity 
reduction when either tau isoform is added to MTs stabilized with either epothilone 
compound at a tubulin:tau ratio of 5:1. The speed reductions are smaller as compared to those 
measured using the QD assay, with tau-dependent reductions of ~ 15-18%, in contrast to the 
43-48% reductions we observed with the QD assay. When compared to the velocities at 
which tau-coated taxol-stabilized MTs move, we again measure smaller differences than 
were observed with the QD assay. We find significant reductions in gliding velocities of MTs 
79 
 
coated with the 4R tau isoform for both epothilone compounds (p  < 0.001). For the 3R tau 
isoform, we find even smaller differences between the speeds of MTs stabilized with either 
epothilone compound and taxol. When the MTs are coated with 3R tau, the reduction in 
gliding velocities for epothilone-A-stabilized MTs as compared to taxol-stabilized MTs is 
significant, although the p-value is smaller (p  < 0.01); for 3R tau coated MTs, the velocity 
difference between the taxol-stabilized MTs and epothilone-B-stabilized MTs is not 
significant. 
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Figure 4-1: Results of Cosedimentation Assay.  The ability of tau to bind to epothilone-
stabilized MTs was assessed for both epothilone-A and epothilone-B. These data were 
compared to cosedimentation data obtained with taxol-stabilized and tau-assembled MTs. In 
each case, two tubulin:tau ratios were tested, 30:1 and 5:1 which span the physiological range 
in neurons, for both 3R and 4R tau. Full statistical analysis of these data is given in Table I. 
For each condition, the number of data points N = 2 or 3. Error bars are SEM. *Previously 
reported values [9]. 
 
 
Figure 4-2: Microtubule stiffness as a function of stabilization condition and tau. MT 
stiffness is determined from the spectrum of thermal fluctuations of freely-diffusing 
filaments. MTs are stabilized by either epothilone-A, epothilone-B, or taxol, then coated with 
no tau, 3R tau, or 4R tau at tubulin:tau ratio of 5:1. Under each condition we find the 
distribution in stiffness determined from an ensemble of different MTs (N = 25 – 78). Box 
and whiskers plot is constructed as follows.  The middle line of each box represents the 
median, the upper box edge represents the 75th percentile, the lower box edge represents the 
25th percentile, and the upper and lower whisker extensions represent the 90th and 10th 
percentiles, respectively. Raw data distributions are shown in Figure S1. 
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Figure 4-3: Kinesin velocity as a function of stabilization condition and tau. Kinesin 
velocity is determined using an MT gliding assay (upper panel, N = 72 – 354) or QD assay 
(lower panel, N = 22 – 93). MTs are stabilized by epothilone-A, epothilone-B, or taxol, then 
coated with no tau, 3R tau, or 4R tau. Full statistical analysis of these data is given in Table 
II. Error bars are SEM. *Previously reported values [9]. Raw data distributions are shown in 
Figures S2 and S3. 
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E. Discussion 
There have been several prior studies of the effects of tau on MT stiffness. In the absence of 
small molecule stabilizers, MTs that have been polymerized in the presence of GTP with 
GMPCPP stabilizing caps were measured to have a mean Lp of ~ 6.0 mm at 37°C using a 
similar spectral analysis method [80].  For MTs that are polymerized in the presence of taxol 
without GMPCPP caps, the mean Lp has been measured by spectral analysis to be 7.5 mm at 
37°C and 4.9 mm at 25°C [78, 80].  The stiffness of MTs polymerized in the presence of a 
recombinant bovine tau protein with 4 binding repeats and 2 projection domains at a molar 
ratio of ~5:1 tubulin:tau, but without small molecule stabilizers, was determined to be 
7.9 mm [80].   
 
A second prior approach examined the shape changes of MTs that are actively bent using 
optical tweezers, then allowed to relax back to their equilibrium shape by moving through a 
viscous buffer [76, 77]. Using this relaxation method, the persistence length of MTs grown 
off an axoneme template under various polymerization conditions was determined for MTs at 
room temperature (22°C –25°C). In the absence of stabilizing compounds or tau, the mean Lp 
was measured to be 0.9 mm, and in the presence of taxol this value decreases to 0.2 mm [77]. 
Although there are significant variations in the stiffness values determined by different 
methods (as reviewed in [120]), the hydrodynamic relaxation methods tend to give 
systematically lower values for stiffness than do the methods that employ spectral analysis of 
thermal fluctuations. The role of taxol in determining MT stiffness has been particularly 
controversial, although most measurements have indicated that the addition of taxol softens 
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MTs [120]. Consistent with this, we have found that the addition of taxol to GMPCPP-
stabilized MTs reduces MT stiffness (data not shown).  
 
To our knowledge, there have been no measurements of the effects of epothilone compounds 
on MT stiffness, however, a number of structural studies have indicated that epothilone 
binding induces tubulin conformational changes.  Hydrogen-deuterium exchange mass 
spectroscopy experiments have shown that epothilone-A, epothilone-B, and a synthetic 
analog of epothilone-B called ixabepilone improve longitudinal contacts at the interface 
between tubulin dimers along a single protofilament and have little effect on the lateral 
interactions between protofilaments [121, 122].  Similar interactions were observed when 
MTs were stabilized by docetaxel, a compound related to taxol [121]. The epothilones and 
taxol appear to bind to the same (or overlapping) sites on the tubulin dimer, and to stabilize 
MTs in a similar manner [123]. MTs stabilized by either taxol or epothilone-B have been 
found to have similar architecture, with the epothilone-stabilized MTs being slighter larger in 
diameter:  60% or 35% of taxol-stabilized MTs have 12 or 13 protofilaments, whereas 22% 
or 67% of epothilone-B-stabilized MTs have 12 or 13 protofilaments, respectively [124]. 
Given this, the origins of decreased stiffness with the epothilone compounds are not clear. 
 
In the absence of small molecule stabilizers, the addition of a wide variety of tau constructs 
uniformly increased MT stiffness, as measured by hydrodynamic relaxation [76]. When MTs 
were assembled with the tau construct most similar to our 3R tau (the HT23 construct with 
three MT binding repeats and zero projection domains) the mean Lp value increased from 
0.9 mm to 2.1 mm when the MT surface wass nearly saturated with tau. When a four-repeat 
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tau construct with two projection domains (the HT40 construct, or the ‘long’ form of 4R tau) 
was used at a concentration near MT saturation, the MT Lp was 2.5 mm. When the 
concentration of HT40 was systematically increased from ~2% to ~ 85% of saturation, the 
measured Lp values increased monotonically. 
 
Our results extend this prior work in two ways. After confirming that MTs stabilized by both 
epothilone-A and -B were able to bind tau proteins at affinities that were similar to taxol-
stabilized MTs, we determined the effects of these non-taxol small molecule stabilizers on 
MT stiffness. We find that in the absence of tau proteins, epothilone-stabilized MTs are 
substantially less stiff than those stabilized by taxol, and that epothilone-A- and -B-stabilized 
MTs have slightly different stiffnesses. Of all three stabilizing compounds, epothilone-B 
MTs are most flexible. When we add either the 3R or 4R ‘short’ tau constructs, to the taxol- 
or epothilone-A-stabilized MTs, the stiffness decreases. For epothilone-B stabilized MTs, 
there is no clear effect with the addition of tau. This is in contrast to prior work on MTs 
assembled by tau in the absence of stabilizing drugs, in which the addition of tau proteins has 
always increased stiffness. Interestingly, the stiffness differences that we observed using 
MTs formed by different stabilizing compounds in the absence of tau nearly vanish.  
 
The molecular-level changes that give rise to this tau-dependent reduction in stiffness in the 
presence of small-molecule stabilizers are not clear. Possible mechanisms include either a 
reduction in the number of protofilaments upon addition of tau, or a change in the inter- or 
intra-protofilament interaction energy that would lead to a reduction in the effective bending 
modulus of the MT. For the case of taxol-stabilized MTs, the addition of any of the six 
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naturally-occuring isoforms of tau has been shown to increase the average MT protofilament 
number in a tau concentration-dependent manner [125]. This suggests that at least for taxol-
stabilized MTs, the reduction in stiffness due to tau addition must arise from changes in the 
interaction energies between tubulin dimers. To our knowledge, the effects of epothilone 
compounds on MT structure in the presence of tau are unknown.  
 
We also tested the ability of epothilone-stabilized MTs to support kinesin translocation using 
two experimental geometries in the QD and MT gliding motility assays. In the absence of 
tau, both epothilone-A and -B are able to support kinesin-driven motility, at speeds that are 
similar to and in most cases indistinguishable from that of taxol-stabilized MTs. For all small 
molecule stabilizers, we find that the addition of tau decreases kinesin velocity. In almost all 
cases, the reductions observed are greater when MTs are stabilized with an epothilone 
compound rather than taxol. The tau-dependent reductions are markedly larger for the 
epothilone compounds when the QD assay is used.  
 
We suspect that the origins of these differences arise due to the different binding geometries 
in the QD and gliding assays. In the MT gliding assay, large ensembles of kinesin motors 
work cooperatively to move a microtubule, whereas in the QD assay only 2-3 kinesin motors 
are actively engaged at any one time. It is possible that the topography of the epothilone-
stabilized MTs differs from that of the taxol-stabilized MTs in a manner that causes the 
kinesin motors to adopt different trajectories along the surface. Since the QD assay averages 
the motions of a small number of motors, any instantaneous changes in stepping patterns due 
either to direct tau-kinesin interactions, or to tau-dependent differences in the tubulin-kinesin 
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interactions may be more evident in the QD assay than in the MT gliding assay that averages 
over a much larger ensemble.  
 
Alternatively, it is possible that the differences observed using the MT gliding and QD assays 
arise from subtle changes in tau concentration in the two assays. The multiple wash steps and 
buffer exchanges used in the preparation of the immobilized MTs and kinesin-QD complexes 
prevent knowledge of the absolute tubulin:tau molar ratio, whereas the MT gliding assay 
maintains a well-defined tubulin:tau ratio of 5:1.  However, we have tested the effects of tau 
concentration on kinesin translocation using taxol-stabilized MTs and found no change in 
velocity for tau concentrations ranging from 100 nM to 1 M, consistent with prior results. 
Moreover, the QD assay preparation is identical for MTs polymerized with each small 
molecule stabilizer, and we control the average number of MTs per field of view for each 
experiment. Thus even if some of the differences we observe between the QD and MT 
gliding assays do arise from changes in bound tau concentration, we expect that the 
differences observed between the taxol- and epothilone-stabilized MTs using the QD assay 
do not. 
 
In summary, we find the MTs stabilized by either epothilone-A or epothilone-B are 
competent to bind tau proteins, and support kinesin translocation. However, epothilone-
stabilized MTs are substantially less stiff than taxol-stabilized MTs, and the addition of tau 
proteins to MTs stabilized by either epothilone-A or taxol further reduces stiffness. Kinesin 
translocation is also affected not only by the presence of tau, but by the type of small 
molecule stabilizer used.  These results suggest that small molecule stabilizers do not simply 
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stabilize a “native” MT structure, but rather are active agents that remodel MT structure, 
function, and mechanics. This may have important consequences to the use of these agents as 
chemotherapeutics. One possible outcome of our work is the development of functional 
screening methods to select and optimize chemotherapeutic compounds with minimal 
impacts on MT stiffness, kinesin translocation, and axonal transport. 
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V. Effect of disease-linked tau mutants on taxol-assembled 
microtubule mechanics 
This chapter will discuss the effects of disease-related tau mutants on the mechanical 
properties of taxol-assembled microtubules. 
 
A. Abstract 
Using the biochemical and biophysical tools that we have developed in the previous sections, 
we investigated the effects of three different tau proteins, each with a different single-point 
mutation, on the mechanical properties of microtubules (MTs) that were assembled in the 
presence of taxol. We found that MTs that are assembled with taxol and coated with R406W, 
P301L or ΔN296 tau mutants have persistence lengths similar to those of taxol-assembled 
MTs in the absence of tau. Other than the 4RS ΔN296 mutant, the persistence lengths of all 
mutant tau-coated MTs (3RS R406W, 4RS R406W and 4RS P301L) are significantly higher 
than MTs coated with their corresponding wild-type tau (3RS WT and 4RS WT) constructs. 
The discrepancies in MT stiffness suggest that the binding of mutant tau proteins can affect 
the “native” structure and modify the mechanics of the MTs differently compared to the 
wild-type constructs. Although the differences are subtle, small defects in MT regulations in 
neurons may over time contribute to severe diseases, such as dementia.  
 
B. Methods 
Taxol-assembled MTs were generated using the same method as in Chapter II (See Tubulin 
preparation and microtubule assembly, Page 65). Microtubule fluctuation assays were 
conducted as described previously in Chapter IV (See Microtubule Fluctuation Assays, Page 
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68) with minor modification. After the polymerization reaction has completed, one of the tau 
constructs (3RS WT, 4RS WT, 3RS R406W, 4RS R406W, 4RS P301L, 4RS ΔN296) is 
added to solution at a 5:1 molar ratio of tubulin:tau (final concentration of 100 nM). The 
statistical significance of the persistence length differences we observe data was determined 
using a built-in non-parametric Kolmogorov-Smirnov test algorithm in MATLAB. 
 
C. Results and Discussion 
Using the spectral analysis technique described in Chapter III (See Page 34), we measured 
the persistence lengths, Lp, of taxol-assembled MTs coated with one of the six tau constructs 
(3RS WT, 4RS WT, 3RS R406W, 4RS R406W, 4RS P301L, 4RS ΔN296) at a 5:1 molar 
ratio of tubulin:tau. In agreement with ourprevious results and the obervations of others, the 
distributions of MT persistence lengths were non-Gaussian [9, 59], and again we characterize 
the MT persistence length at each condition by the median value, and graphically present the 
distributions using a box and whisker plot format. As shown in Figure 5-1, the median 
persistence length of taxol-assembled MTs in the absence of tau is 2.0 mm. The median 
persistence lengths reduce to 1.1 mm and 1.3 mm upon the addition of 3RS WT and 4RS WT 
tau, respectively. The median persistence lengths measured for MTs that are assembled by 
taxol and then coated with one of the four mutant tau constructs are 2.0 mm for 3RS R406W, 
2.0 mm for 4RS R406W, 1.9 mm for 4RS P301L and 1.6 mm for 4RS ΔN296. We tested the 
statistical significance of the persistence length distributions using a non-parametric two-
sample Kolmogorov-Smirnov test. As shown in Table 5-1, the persistence lengths on MTs in 
the absence of tau are significant stiffer than those of MTs coated by either of the 3RS WT 
and 4RS WT tau proteins. The mutant tau-coated MTs showed no difference in MT stiffness 
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compared to the no tau condition, but all are significantly stiffer than their corresponding 
wild-type tau construct, except for 4RS ΔN296. 
 
The differences in stiffness and persistence lengths between some of the wild-type tau and 
mutant tau constructs suggest possible differences in MTs structure modifications. A 
previous study showed that the addition of tau as a secondary stabilizer, after MTs were 
assembled in the presence of taxol, modifies the radius of curvature of the MT surface and 
increases the average protofilament number of the MTs [6]. With our assumption that MTs 
are homogeneous and isotropic, the bending stiffness is equal to EI, where E is the effective 
Young’s modulus, and I is the second moment of area of the MT cross-section, which 
roughly scales as the fourth power of the MT radius. The increase in protofilament number 
will necessarily increase the radius of the MTs, which will in theory lead to an increase in 
stiffness. However, we observed lower MT stiffness in the presence of wild-type tau, which 
was contradicted to our expectation. Although the underlying mechanism is not understood at 
this point, we suspect that the binding of tau alters the arrangements of tubulin dimers and 
modifies the inter- and intra-protofilamental energy landscape along the MTs, which lowers 
the effective Young’s modulus of the MTs to (over)compensate for the effect of increasing 
radius and the second moment of area.  Additionally, it is possible that mutations in the tau 
sequence can also lead to different binding behaviors, as recent results in our lab have found 
evidence of cooperative binding behavior in a similar microtubule-associated protein (MAP) 
binding system of EB1 [126]. The differences in tau-tau interactions can lead to abnormal 
clumpings or aggregations that create greater geometric changes on the MT surface and 
larger accumulated electrostatic effects on the binding energy landscape. Despite all these 
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possible models of what may happen in the MT structure, we should be cautious about 
interpreting the results from this study since the MTs in the experiments were assembled in 
the presence of small molecule stabilizer taxol. As we have discussed in studies in Chapters 
II and IV, these small molecule stabilizers do not simply stabilize the “native” structure of 
MT. We have seen multiple incidents of these small molecule stabilizers “locking” MTs in 
specific structures that mask the potency of a secondary stabilizing agent such tau on the 
mechanical and functional properties of MTs. Recently, we have looked at the mechanical 
properties of MTs that were assembled in the presence of WT tau without the inclusion of 
taxol. The persistence lengths of these tau-assembled MTs were much higher (~10 mm, data 
not shown) compared to any of our taxol-assembled tau-coated MTs. These results further 
bolster our theory that MT properties, mechanical and functional, were dominated by the first 
stabilizer used during MT assembly, which limits the effects of secondary stabilizers. One 
must pay attention to the assembly conditions and the order of addition of different 
stabilizing agents when conducting future experiments on microtubule-related subjects. 
Future high-resolution single-filament structure measurements on the MT lattice structure 
under various assembly and stabilization conditions will be essential to understand the 
molecular mechanisms driving the observed changes in MT mechanics.  Of particular interest 
are super-resolution imaging methods that may allow for dynamic measurements of the 
binding and motions of tau proteins on the MT lattice. 
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Figure 5-1: Microtubule stiffness in various conditions. MT stiffness is determined from 
the spectrum of thermal fluctuations of freely-diffusing filaments. MTs are assembled by 
taxol, then coated with no tau, 3RS WT, 4RS WT, 3RS R406W, 4RS R406W, 4RS P301L or 
4RS ΔN296 tau at tubulin:tau ratio of 5:1. Under each condition we find the distribution in 
stiffness determined from an ensemble of different MTs (N = 27 – 78). Box and whiskers 
plot is constructed as follows.  The middle line of each box represents the median, the upper 
box edge represents the 75th percentile, the lower box edge represents the 25th percentile, and 
the upper and lower whisker extensions represent the 90th and 10th percentiles, respectively. 
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Table 5-1: Statistical Analysis of Persistence Length Data 
Condition 1 Condition 2 h 
No Tau 3R WT 1 
No Tau 4R WT 1 
No Tau 3R R406W 0 
No Tau 4R R406W 0 
No Tau 4R delN296 0 
No Tau 4R P301L 0 
3R WT 4R WT 0 
3R WT 3R R406W 1 
3R WT 4R R406W 1 
3R WT 4R delN296 1 
3R WT 4R P301L 1 
4R WT 3R R406W 1 
4R WT 4R R406W 1 
4R WT 4R delN296 0 
4R WT 4R P301L 1 
3R R406W 4R R406W 0 
3R R406W 4R delN296 0 
3R R406W 4R P301L 0 
4R R406W 4R delN296 0 
4R R406W 4R P301L 0 
4R delN296 4R P301L 0 
A two-sample Kolmogorov-Smirnov test (MATLAB) is used to 
analyze the statistical differences of microtubule persistence 
lengths between different conditions. A h value of 1 indicates a 
significant difference at 95% confidence level. 
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VI. The Effects of Tau on Intracellular Trafficking in COS-7 Cells 
In this chapter, we will discuss the effect of WT and mutant forms of tau on cytoskeletal 
structure and intracellular transport in non-neuronal COS-7 cells. 
 
A. Abstract 
Tau proteins are expressed abundantly in human neurons, and are known to regulate the 
dynamics and structures of cytoskeletal microtubule filaments. Tau mutations and 
misregulation can cause severe neurodegenerative diseases including Alzheimer’s disease, 
frontotemporal dementia with parkinsonism-17, progressive supranuclear palsy, and 
corticobasal degeneration. We previously showed that 4RS wild-type (WT) tau proteins and 
4RS tau mutants (R406W, P301L, N296) can inhibit the efficiency of kinesin-driven cargo 
transport along microtubules in a simplified in vitro environment. This cellular mechanism is 
extremely important as it regulates the chemical balance inside the cytoplasm. Moreover, the 
transport of vital organelles and other molecules through substantial distances across the cell 
is impossible to achieve efficiently via random diffusion. This active transport mechanism is 
utilized by many biological and therapeutic processes such as virus infection, gene therapy, 
and drug delivery. In this study, we used a combination of biophysical tools and imaging 
techniques to investigate the effects of transient tau expression on lysosome transport in 
COS-7 African green monkey kidney tissue cells, which are natively tau-free. We found that 
the introduction of tau proteins (either wild-type or mutant tau) dramatically rearranges the 
structure of microtubule networks in the COS-7 cells, yet the modifications in the 
cytoskeletal networks had little effect on the speed and run length of motor-driven direct 
lysosome transports in the cells. This suggests that localized transport events are insensitive 
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to the global structure of the MT cytoskeleton, and that MT bundling and aggregation do not 
substantially impair motor-driven transport. Additionally, although the introduction of tau 
clearly impacted MT organization, we found little evidence that the disease-linked tau 
mutants were particularly toxic, in fact we found mutant and WT tau forms led to similar 
overall structures and transport phenotypes.  
 
B. Methods 
1. Cell Culture 
COS-7 African green monkey kidney tissue cells were maintained in maintenance medium 
composed of Dulbecco’s Modified Eagle’s Medium supplemented with 5% horse serum 
(Cellgro, 35-030-CV), 5% supplemented calf serum (HyClone, SH30072.03), 44 µM sodium 
bicarbonate and 1% Antibiotic-Antimycotic (Gibco, #15240-062) at 37°C and in a 
humidified, 7.5% CO2 atmosphere. Cells were maintained at a subconfluent density and were 
split 1:5 every roughly 2-3 days to ensure that cells were not overly populated. Cells were 
trypsinized (Gibco, 25300-054), resuspended in antibiotic-free maintenance medium and 
plated on coverslip-bottomed culture dishes (Bioptechs) coated with poly-L-lysine (50 
µg/mL, Sigma) at a concentration of 0.25×104 cells/cm2 two hours prior to transfection. We 
note that, in vivo studies with tau proteins may be easier to interpret in primary neuron 
cultures or using other neuron-related cell types, such as PC12 cells, a line derived from a 
pheochromocytoma of the rat adrenal medulla which can be induced to adopt a neural 
morphology under treatment by nerve growth factor, which both have native expression of 
tau proteins to regulate MT growth and structures [61]. Unfortunately, and despite substantial 
time investment and effort, we had technical difficulties in culturing and expressing tau in 
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PC-12 cells, and eventually decided to move forward with the COS-7 line, which has been 
extensively used in biophysical studies, particularly of intracellular transport [127]. COS-7 
cells have the distinct advantage that they lack endogenous tau, so there is no population of 
WT tau to dilute the effects of the mutants. 
 
2. Tau DNA and transfection 
The PAAV-IRES-hrGFP (Strategene, 240075) expression vector containing an insert of 
human cDNA sequences for 3-repeat short or 4-repeat short tau isoforms was used to 
introduce tau proteins in COS-7 cells. The expression vector substrate contains a CMV 
promoter, which is compatible with mammalian cells and a separate internal ribosome entry 
site (IRES) for GFP expression. The fluorescence signal from the freely diffusing GFP 
proteins acts to identify the transfected cells within the ensemble (transfection efficiency is 
typically ~20%). Single point mutations (P301L, R406W and ΔN296) were introduced into 
the 4-repeat tau gene using the QuickChange II site-directed mutagenesis kit (Agilent 
Technologies, 200523). The vector containing the tau sequence of interest (1 µg) was 
transfected into the COS-7 cells 2-hrs after seeding in coverslip-bottomed culture dishes, as 
described previously (Cell culture, page 97) using the PolyJet transfection reagent (3 µL, 
SignaGen, SL100688). The plasmid/PolyJet containing media was removed and replaced 
with fresh maintenance media 18 – 20 hours post-transfection.  
 
3. Lysosome labeling, image acquisition and tracking 
COS-7 cells were visualized using fluorescence microscopy 1-2 days after transfection. 
Before imaging, lysosomes in the cells were fluorescently labeled using LysoTracker Deep 
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Red (50 nM, Life Technologies) at 37°C for 30 minutes. The media containing LysoTracker 
was then replaced with Live Cell Image Solution (Life Technologies, A14291DJ) 
immediately before imaging. Cells were visualized with an Olympus DSU Confocal 
microscope, using the 100X oil immersion objective (NA = 1.X) and with spinning disk 
removed to allow for epifluorescence illumination. The cells are maintained at 37°C using a 
heated environmental enclosure. All imaging was performed at the UCSB NRI-MCDB 
Microscopy Facility. Images were obtained using a Hamamatsu ImaEM CCD camera with a 
frame rate of 0.5 Hz for a total collection time of 100 seconds. Lysosomes in the image series 
were tracked using the MOSAIC particle tracking algorithm available as an ImageJ plugin 
[128]. Tracking parameters were optimized to eliminate tracking errors (Radius = 4, Cutoff = 
0, Percentile = 0.1%, Link Range = 2, Displacement = 9). 
      
4. Trajectory analyses 
One challenge of this research is identifying and selecting the motor-driven motions of the 
fluorescent lysosomes from among the large data set of diffusive and non-directional motions 
of non-motor driven cargoes.  To accomplish this, multiple selections were performed to 
identify motor-bound lysosomes that underwent directed processive transport. Initially, only 
those tracked lysosome trajectories that persisted for at least 30 frames were selected to 
warrant their validity to perform additional analysis. To distinguish processive cargoes from 
those that are diffusing or are not moving at all, we performed the Speed Correlation Index 
analysis, as described in Bouzigues and Dahan, 2007 [129]. Trajectories were first divided 
into different sets of a multi-segment system with segments of equal lengths (See Figure 6-
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1); then the directional correlations between neighboring segments were calculated for each 
set as following:  
ܥ௞ሺ݅ሻ ൌ ܷ௞ሺ݆ሻ ∗ ܷ௞ሺ݆ ൅ 1ሻ|ܷ௞ሺ݆ሻ||ܷ௞ሺ݆ ൅ 1ሻ| 
where Ck (i) is the speed correlation index, ranging from 0 to 1 (0 indicates complete 
uncorrelated random motion, and 1 indicates perfectly correlated motion),at point i in set k, 
Uk (j) and Uk (j+1) are the average velocity vector of segment j, which contains point i, and 
the neighboring segment j+1. The average correlation, C(i), was then calculated at point i 
over all k segment sets. Segments that contained consecutive points with high correlation 
index indicate correlated directional motions. Parameters in the analysis such as segment 
length and threshold value of correlation index were determined and optimized in simulated 
trajectories of pure random diffusion that closely mimicked the actual experimental 
environment (Data not shown). Based on the outcomes of these simulations, sections in the 
trajectories with correlation indexes higher than 0.6 (segment length = 5) that persisted for 
more than 15 points were selected for further analyses.  Trajectories were divided into runs 
that were categorized as anterograde (+, toward cell periphery) or retrograde (-, toward cell 
center) based on the directions of the movements in relation to the radial vectors from the 
centers of the cells. A displacement was anterograde if the angle between the displacement 
vector and the radial vector from the cell center was less than 90°, in all other cases this 
trajectory be tagged as retrograde. The mean speed and run length (total travel distance) of 
each run was measured. 
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Figure 6-1: Speed correlation index analysis. Trajectory were divided into segments of equal 
length L, in this case L = 4. Different sets of segments were generated by shifting the origin 
of the original segment set by 0, 1, ..., L-1. 
 
5. Immunofluorescence 
Cells were first fixed with warm 3.7% formaldehyde (37°C) for 8 minutes at 37°C. Cells 
were then subsequently fixed in chilled 100% methanol (-20°C) for 5 minutes. Fixed cells 
were rehydrated with PBST buffer (0.1% Triton-X-100 in PBS) and incubated in PBST 
blocking buffer (1% BSA, 1% donkey serum, and 0.1% Triton-X-100 in PBS) for 30 
minutes. Cells were incubated overnight first with rabbit monoclonal anti-alpha tubulin 
antibody (1:500, EMD Milipore), then incubated overnight in the presence of Cy5-
conjugated goat anti-rabbit secondary antibody (1:400, Jackson ImmunoResearch). Tau 
proteins in the fixed cells were labeled with Tau 5 mouse anti-rat antibody (1:500, BD 
Biosciences) for 1 hour, followed by Cy3-conjugated goat anti-mouse secondary antibody 
(1:400, Jackson ImmunoResearch) for 1 hour. All incubations with antibodies were done at 
room temperature. Cells were washed 4 times for 8 minutes per wash cycle with PBST after 
each antibody incubation. Images were obtained using Olympus Fluoview 1000 Spectral 
Confocal, with a 60X silicone oil immersion objective (NA = 1.X) at the UCSB NRI-MCDB 
Microscopy Facility.  
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C. Results 
1. Immunofluorescence images reveal substantial disruption of the microtubule network 
upon the addition of tau 
Previous studies suggest the expression of tau in non-neuronal cell lines, such as Sf9, COS 
and L cells, alters cell morphology and induces formation of microtubule (MT) bundles [130-
133]. We were interested in examining the effects of tau on the MT network morphology and 
structure in the COS-7 cells. We employed immunofluorescence techniques to visualize the 
distribution of MT filaments and tau proteins in cells that were fixed 1-2 days post-
transfection. Surprisingly, the immunofluorescence images in our study showed, for all 
conditions, a diffusive fluorescence signal of tau in transfected COS-7 cells with no apparent 
co-localization with MT filaments.  Despite this, we observed dramatic changes in MT 
network morphology in COS-7 cells after transfection with several prominent features. (1) 
Instead of the long filamentous MTs that we observed in cells without tau expression (Figure 
6-2 1st row, bottom cell 2nd row), we found bright punctate tubulin signals in cells that were 
transfected with tau after one day. These punctate spots were indications of possible 
disruption and aggregation of unpolymerized tubulins. (2) We also observed thick 
“membrane-associated” MT bundles near the cell peripheries in the majority of transfected 
cells (Figure 6-2, 3rd row), which transformed the MT network from an “aster-like” 
morphology to a radial, “wheel-like” geometry. (3) Lastly, we found the formation of “axon-
like” MT bundles into extended “processes” between transfected cells and neighboring cells 
(Figure 6-2, 4th row). These phenotypic features were observed for all tau constructs (3RS 
WT, 4RS WT, 4RS P301L, 4RS R406W, and 4RS ΔN296). Additionally, these phenotypic 
features appeared to be more prominent in COS-7 cells two days after transfections, when 
103 
 
more bundling and more membrane association was observed (Figure 6-3). Higher tubulin 
fluorescence intensity was also found in cells 2-days post-transfection as compared to cells 
that were transfected and then fixed after only one day (Figure 6-3).  
 
2. Addition of tau in COS-7 cells reduces cargo velocity 
Another focus of this study is to assess the effect of tau on cargo trafficking inside COS-7 
cells. We fluorescently labeled lysosomes in the cells using LysoTracker Deep Red reagent 
and imaged using fluorescence microscopy. Time-lapsed images were collected and analyzed 
with well-developed particle tracking algorithm. Unlike the in vitro studies that we discussed 
in Chapters II and IV, the environment in the cellular system is much more complex as we 
had less control over the surrounding composition and distribution of the microtubule (MT) 
filaments and labeled particles in the experiments. Furthermore, cargoes in cells are typically 
carried with multiple motors and also different types of motors in comparison to the 
simplified Q-dot assay in our in vitro studies where particles were coated only with purified 
kinesin proteins and only moved along isolated MTs. As a result, cargoes in cells are able to 
move in both directions along MT filaments and exhibit many different moving behaviors 
due to geometry constraints and physical hindrances.  
 
Lysosomes that were undergoing directed transport were selected for velocity analysis. 
Trajectories were divided into runs that were categorized as anterograde (+, toward cell 
periphery) or retrograde (-, toward cell center) based on the direction of the particle motion 
with respect to the center of the cell. The average speed of each run was measured as 
described previously (Methods: Trajectory analyses, Page 99). Based on the overall 
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organization of the MT cytoskeleton, and many prior studies of MT-based transport, we 
assume that the motions along different directions of the MTs were driven by different 
groups of motor proteins. Anterograde transports are known to be dominated by kinesin 
motors, whereas retrograde transports are handled by dyneins. These two families of motor 
proteins were found in previous studies to have different structures and different stepping 
behaviors [134, 135]. Therefore, we would expect to see differences in the velocities 
measured in different directions. Interestingly, as shown in Figure 6-3, the mean velocities 
measured in our experiments for anterograde and retrograde lysosome transports are 
surprisingly similar for most of our conditions. We conducted statistical analysis to compare 
the anterograde and retrograde velocities measured in each condition using a two-sample 
Kolmogorov-Smirnov algorithm (MATLAB), and found no statistical significance in any of 
the conditions based on a 95% confidence level. 
 
We next examined the effect of tau on anterograde (kinesin-driven) lysosome transport. 
Without the introduction of tau, lysosomes that were transported in the anterograde direction 
had an average velocity of 397 ± 34 nm/s. One day after transfection, the average 
anterograde velocities dropped to 253 ± 48 nm/s for 3RS WT, 361 ± 50 nm/s for 4RS WT, 
294 ± 27 nm/s for 4RS P301L, 285 ± 28 nm/s for 4RS R406W, and 264 ± 20 for 4RS 
ΔN296. Some of the differences seemed to be substantial, yet only the average anterograde 
velocities of lysosomes in 4RS R406W and 4RS ΔN296 transfected cells were statistically 
different to that measured using the no tau condition. None of the lysosome anterograde 
speeds for cells expressing the tau mutants were statistically different than for cells 
expressing wild-type 4RS WT. After two days of transfection, we measured the average 
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anterograde velocities to be the following: 272 ± 52 nm/s for 3RS WT, 248 ± 32 nm/s for 
4RS WT, 310 ± 31 nm/s for 4RS P301L, 393 ± 47 nm/s for 4RS R406W, and 350 ± 28 nm/s 
for 4RS ΔN296. When we compare the anterograde velocities of lysosomes moving in cells 
expressing the two wild-type constructs to a no tau control, we found a significant reduction 
in speed according to the Kolmogorov-Smirnov test.  On the other hand, the lysosome 
velocities for cells expressing the mutants showed no statistical significance as compared to 
the cargo speeds for cells without tau, suggesting that the mutant-tau-containing cells 
eventually recover in a way that the WT-tau-containing cells do not. The full statistical 
analysis is shown on Table 6-1. 
 
Similarly for retrograde (dynein-driven) lysosome transport, the average velocities dropped 
one day after transfection from the no tau velocity of 378 ± 34 nm/s to 341 ± 57 nm/s for 
3RS WT, 280 ± 37 nm/s for 4RS WT, 269 ± 25 nm/s for 4RS P301L, 253 ± 25 nm/s for 4RS 
R406W, and 254 ± 29 nm/s for 4RS ΔN296. The velocities in mutant-expressing cells were 
significantly different than the no tau velocities, while the wild-type velocities were not. In 
contrast to the kinesin-driven transport, in no case were the cargo speeds for the 4RS mutant-
expressing cells statistically significant compared to 4RS WT. On Day 2 after transfection, 
we again observed the recovery of average retrograde velocities for tau mutants to 320 ± 30 
nm/s for 4RS P301L, 290 ± 38 nm/s for 4RS R406W, and 367 ± 29 nm/s for 4RS ΔN296, 
while the average velocities for wild-type constructs decreased further to 261 ± 37 nm/s and 
265 ± 34 nm/s for 3RS WT and 4RS WT, respectively. More statistical test results can be 
found in Table 6-1. Distributions of lysosome velocities and run lengths are shown in Figure 
S6-1, S6-2 and S6-3, yet we did not notice any obvious trends or outliers from the 
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distribution histograms, again suggesting that the mutant and WT type forms had similar 
effects on motor-driven transport.    
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Figure 6-2: Representative immunofluorescence images of COS-7 cells. The addition of 
tau caused disruptions in the microtubule network. Row 1 (No tau) shows regular 
microtubule networks in COS-7 cells. Row 2 (4RS WT day 1) shows signs of unpolymerized 
tubulin aggregations (magenta arrows). Row 3 (4RS R406W Day 2) shows formations of 
thick microtubule bundles in near cell peripheries (white arrows). Row 4 (4RS ΔN296 Day 1) 
shows formations of microtubule bundle do “processes” (light blue arrows).
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Figure 6-3: Microtubule network morphology comparisons between 1-day and 2-day post-transfection in COS-7 cells. Cell that 
was transfected with tau (4RS P301L) for two days (Row 2) displayed more prominent bundling of microtubules near cell periphery 
and had more tubulin/microtubule content in the cell compared to cells that were transfected with tau for one day. 
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Figure 6-3: Mean velocities of lysosomes transported directionally in anterograde and retrograde directions. Trajectories of 
selected lysosomes were divided into runs that were categorized as anterograde (+, toward cell periphery) or retrograde (-, toward cell 
center) based on the direction of the particle motion with respect to the center of the cell. The average velocity of each run was 
displayed above (N = 19 -106). Error bars are SEM.  
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Figure S6-1: Average lysosome velocity distributions for cells that had no tau, 3RS WT tau and 4RS WT tau 1-day after 
transfection. Velocities in the anterograde (towards cell periphery) direction are positive, and velocities in the retrograde (towards 
cell center) direction are negative. 
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Figure S6-2: Average lysosome velocity distributions for in cells that were transfected with 4-repeat wild-type and mutant tau 
for one and two days. Velocities in the anterograde (towards cell periphery) direction are positive, and velocities in the retrograde 
(towards cell center) direction are negative. 
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Figure S6-3: Lysosome run lengths distributions for COS-7 cells with no tau and cells transfected with 3RS and 4RS wild-type 
tau 
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Figure S6-4: Lysosome run lengths distributions for tau-transfected (4RS WT, 4RS P301L, 4RS R406W and 4RS ΔN296) cells
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Table 6-1: Statistical Analysis of Lysosome Velocities 
Condtion 1 Condition 2 h, anterograde h, retrograde 
No Tau 3RS WT Day 1 0 0 
No Tau 4RS WT Day 1 0 0 
No Tau 4RS P301L Day 1 0 1 
No Tau 4RS R406W Day 1 1 1 
No Tau 4RS ΔN296 Day 1 1 1 
No Tau 3RS WT Day 2 1 1 
No Tau 4RS WT Day 2 1 1 
No Tau 4RS P301L Day 2 0 0 
No Tau 4RS R406W Day 2 0 1 
No Tau 4RS ΔN296 Day 2 0 0 
3RS WT Day 1 4RS WT Day 1 0 0 
3RS WT Day 1 4RS P301L Day 1 0 0 
3RS WT Day 1 4RS R406W Day 1 0 0 
3RS WT Day 1 4RS ΔN296 Day 1 0 0 
3RS WT Day 1 3RS WT Day 2 0 0 
3RS WT Day 1 4RS WT Day 2 0 0 
3RS WT Day 1 4RS P301L Day 2 0 0 
3RS WT Day 1 4RS R406W Day 2 0 0 
3RS WT Day 1 4RS ΔN296 Day 2 0 0 
4RS WT Day 1 4RS P301L Day 1 0 0 
4RS WT Day 1 4RS R406W Day 1 0 0 
4RS WT Day 1 4RS ΔN296 Day 1 0 0 
4RS WT Day 1 3RS WT Day 2 0 0 
4RS WT Day 1 4RS WT Day 2 0 0 
4RS WT Day 1 4RS P301L Day 2 0 0 
4RS WT Day 1 4RS R406W Day 2 0 0 
4RS WT Day 1 4RS ΔN296 Day 2 0 0 
4RS P301L Day 1 4RS R406W Day 1 0 0 
4RS P301L Day 1 4RS ΔN296 Day 1 0 0 
4RS P301L Day 1 3RS WT Day 2 0 0 
4RS P301L Day 1 4RS WT Day 2 0 0 
4RS P301L Day 1 4RS P301L Day 2 0 0 
4RS P301L Day 1 4RS R406W Day 2 0 0 
4RS P301L Day 1 4RS ΔN296 Day 2 0 0 
4RS R406W Day 1 4RS ΔN296 Day 2 0 0 
4RS R406W Day 1 3RS WT Day 2 0 0 
4RS R406W Day 1 4RS WT Day 2 0 0 
4RS R406W Day 1 4RS P301L Day 2 0 0 
4RS R406W Day 1 4RS R406W Day 2 0 0 
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4RS R406W Day 1 4RS ΔN296 Day 2 0 1 
4RS ΔN296 Day 1 3RS WT Day 2 0 0 
4RS ΔN296 Day 1 4RS WT Day 2 0 0 
4RS ΔN296 Day 1 4RS P301L Day 2 0 1 
4RS ΔN296 Day 1 4RS R406W Day 2 1 0 
4RS ΔN296 Day 1 4RS ΔN296 Day 2 1 1 
3RS WT Day 2 4RS WT Day 2 0 0 
3RS WT Day 2 4RS P301L Day 2 0 0 
3RS WT Day 2 4RS R406W Day 2 0 0 
3RS WT Day 2 4RS ΔN296 Day 2 1 1 
4RS WT Day 2 4RS P301L Day 2 0 0 
4RS WT Day 2 4RS R406W Day 2 1 0 
4RS WT Day 2 4RS ΔN296 Day 2 1 1 
4RS P301L Day 2 4RS R406W Day 2 0 0 
4RS P301L Day 2 4RS ΔN296 Day 2 0 0 
4RS R406W Day 2 4RS ΔN296 Day 2 0 1 
A two-sample Kolmogorov-Smirnov test (MATLAB) is used to analyze the 
statistical differences of lysosome velocities between different conditions. A h 
value of 1 indicates a significant difference at 95% confidence level. 
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D. Discussion 
Intracellular transport is an essential biological process that facilitates and regulates the basic 
functions of a cell. Its role is even more prominent in polarized cell types with long extended 
features such neurons, where important cargos are required to be transported over large 
distances that would be impossible to achieve efficiently with random diffusion alone.  Many 
believed that disruptions in axonal transport could lead to full-blown neurodegenerative 
dementia such as Alzheimer’s and Parkinson’s [8, 10, 27, 29]. Thus, extensive research have 
been conducted on the basis of intracellular transport from in vitro single molecule/filament 
studies on protein motors and microtubule mechanics to in vivo studies on collective 
transports in model cells. Microtubule binding protein tau was identified as a major 
contributor to the regulation of microtubule structures and motor protein transport behaviors. 
Abnormal expressions and defects of tau were found to disrupt motor translocations in vitro 
and in vivo with mechanisms that were not fully understood, but many believed that tau 
proteins interfere by forming physical blockages on MT filaments [7-9]. 
 
In this study, we examined the effects of six different wild-type and mutant tau constructs 
(3RS WT, 4RS WT, 4RS P301L, 4RS R406W, and 4RS ΔN296) on MT network 
morphology and of motor-driven transport properties using COS-7 cells. We observed three 
main phenotypes: 1) formation of bundles (often near the cell peripheries), 2) punctate 
aggregations of what we believe to be non-filamentous tubulins or short tubulin oligomers, 
and 3) formation of “axon-like” “processes” (Figure 6-2). These phenotypes were found in 
all tau-expressing COS-7 cells, and interestingly we did not notice any significant differences 
between the different tau constructs. With these dramatic reorganizations in the MT network 
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structure, one might expect interferences, and inhibitions in intracellular transports, which 
could lead to chemical imbalance and cell death.  
 
Using fluorescence microscopy in combination with advanced image analysis techniques, we 
assessed the effect of tau on the velocities of motor-driven lysosome translocations in the 
COS-7 cells. Surprisingly, despite the massive reorganization in the MT networks, the 
lysosome velocities in tau-expressing cells were not significantly different than that in 
control cells without transfections. We were additionally surprised that there was no 
significant difference between the velocities anterograde and retrograde transports, which 
presumably were driven by different families of motor proteins. Previous in vitro single 
molecule studies showed that kinesins and dyneins have different molecular structures, 
different stepping behavior and different regulations in the presence of tau [7, 136, 137]. 
Thus, we did not expect kinesins and dyneins to behave the same way when encountered tau 
or other types of microtubule binding proteins. However, there was no evidence in our study 
showing differential modifications by tau on transports of different directions. Although the 
molecular mechanism was not well-understood, prior studies often described the behavior of 
in vivo bidirectional cargo transports as a tug-of-war between competing motors [138-141]. 
Therefore, it is possible that the differential effects of tau on individual motors were masked 
by some strange tug-of-war interactions on the multi-motor-bound lysosomes. Another 
possible explanation is that our ability to determine the direction of lysosome motions in tau-
expressing COS-7 cells was compromised by the reorganization of MT networks, where the 
often radial directions of lysosome motion in “wheel-like” networks confounded our 
assignment of motor direction compared to assignments made in the “aster-like” networks we 
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normally found in non-transfected cells. Separate fluorescent labeling of the MT filaments in 
the live-cell experiments could help to better determine the directions of the lysosome 
motions. However, based on the immunofluorescence images that we obtained, the densities 
of the MT filaments in some of the “wheel-like” networks, especially on Day 2, were so high 
that it would be difficult to distinguish the correct direction of a moving lysosome even with 
fluorescently labeled MTs.    
 
One would also expect the average velocities to be hampered incrementally as we increased 
the time post-transfection with presumably higher expressions of tau proteins for longer 
waiting times. However, for some of the mutants (noticeably for 4RS R406W and 4RS 
ΔN296), we observed higher average velocities on Day 2 post-transfection than Day 1. The 
underlying mechanism of the recovery in velocities was not understood, but we can offer 
several possible causes. It is possible that some of these tau mutants lose their effectiveness 
to regulate the intracellular transport system over time, which allow the native regulation 
mechanisms in the COS-7 cells to restore and recover. This may be supported with our 
observation of higher tubulin/microtubule contents in tau-transfected cells on the second day 
(Figure 6-3). On the other hand, we would not rule out the possibility that this apparent 
recovery was an artifact arising from selection bias, where cells with high tau expression 
might be so sick two days post-transfection that most or all active cargo transports were so 
severely disrupted that the only cells that were selected for measurement were those cells that 
were either more tolerant against the effects of tau, or those that had slower expression of tau. 
Instead of looking at time dependence effects of tau expression on intracellular transport, it 
will be interesting for future experiments to quantitatively examine the relationship between 
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expression level of tau and its effect on cargo transport. This will provide tremendous 
insights on not only how neurodegenerative diseases are developed, but also shed light on 
how the progression and severity of the disease are related to the level of tau misregulations.     
 
In summary, we find the addition of tau in natively tau-absent cellular system will cause 
undesirable disruption and misregulations on the intracellular transport system despite use of 
a normal wild-type tau construct. Although we saw little to no effects of tau on lysosome 
transports in COS-7 cells in terms of cargo velocity, we believe that the distributions of 
important organelles were significantly modified due to the changes in MT network 
orientations. These alterations on the delicate intracellular regulation system can possibly 
lead to detrimental effects to the well-being of the cells.    
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VI. Conclusion 
In this research, we tested the effect of microtubule binding tau protein on the microtubule 
mechanics and molecular motor transports in both simplified in vitro settings and a more 
complex cellular system. We had successfully developed useful experimental tools to 
examine the material and functional properties of microtubule. Using these tools, we were 
able to measure the mechanical stiffness of microtubules with great confidence and observe 
changes in their mechanics under different chemical conditions. We gained tremendous 
insight on the determining factors of microtubule mechanics and how we can control and 
modify its material properties in controlled laboratory settings. In addition, we explored how 
the functional properties in terms of cellular transport may be related to these changes in 
microtubule mechanics / structures. We also examined the effects some of the less common 
microtubule stabilizing molecules and proteins such as epothilone-A and –B molecules, and 
tau mutants P301L, R406W and ΔN296, which are related to specific neurodegenerative 
disease. Our studies provides important additional mechanical and functional information of 
these molecules / proteins to the forever expanding list of microtubule stabilizers.  
 
Even though we had found interesting effects of tau on the mechanical properties and 
functional properties of microtubules and intracellular transport, the underlying molecular 
mechanism is still not well understood. There are many speculations in the field on how tau 
interacts and alters microtubule structure and molecular motor translocations along 
microtubules. For a long time, many scientists and biologists believed that tau proteins are 
tightly-bound proteins that binds to the surface of microtubules and stabilize microtubule 
dynamics [40, 43]. Many also suggest that those tau proteins that were bound on the 
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microtubule surface act like physical roadblocks and restrict motor transport [7]. However, 
our microtubule mechanics studies and studies by other suggest that tau proteins do not 
simply bind to the outer surface of microtubule but they are also capable to alter the lattice 
interactions and structure in various assembly conditions [6, 100]. Recent studies also found 
evidence of tau diffusion along mircrotubules which further complicate the interactions 
between tau and microtubule-associated motors [142, 143]. Yet there is a lack of unified 
consensus models on these interactions. We believe that the understanding of the molecular 
mechanisms is crucial for future researches on developing next generation active 
biomaterials and finding possible cures for many neurodegenerative dementias. In order to 
tackle this problem, improvements on high-resolution imaging techniques will be needed in 
combination with sophisticated computer simulations and creative collaborations joining 
expertise across different fields. These studies will open up new ideas and examine various 
molecular interactions in greater detail than are achievable using our more traditional 
experimental methods. In particular, super-resolution structural analyses, such as cryo-EM 
and STORM, will be extremely helpful.  Cryo-EM studies are capable of measuring  the fine 
structural changes in the microtubule lattices and network geometry in various environments. 
On the other hand Stochastic optical reconstruction microscopy or STORM gives real-time, 
dynamic data of microtubules in aqueous environments and has the resolution to monitor 
cargo motions on such finer spatial and temporal scales [144-146]. Future studies using these 
tools will help improve theoretical models for microtubule mechanics and motor stepping 
behaviors, and collaborations to tackle these important issues are now being formed. Lastly, 
it would be  fascinating to further investigate the detailed interactions between molecular 
motors on multi-motor cargoes using a combinations of advanced single-molecule methods 
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and computer simulations. These studies will provide insightful information on how different 
motors, such as kinesin and dyneins, on cellular cargos cooperate and communicate in order 
to accomplish essential tasks such as cellular transport along MAP-coated MTs in an 
efficient manner. 
 
For the cellular work, an important future direction is the development of cell culture lines 
that more accurately mimic the human disease state for biophysical and biochemical 
experiments. This is particularly important for studies of tau, where the isoform distribution 
and regulation can be significantly different among different species. For example, six 
isoforms of wild-type tau proteins can be found in the human central nervous system, 
whereas adult mouse brain only contains exclusively 4-repeat isoforms, an expression profile 
that would be fatal in humans [147]. Thus, we expect that the effects disease-related tau 
mutants and the disease phenotypes could be dramatically different in primary neurons 
harvested from rodents, not to mention other non-neuronal cell lines, compared to real human 
nerve cells. Fortunately, the recent progressions in stem cell technology are bringing the 
promising hopes of producing suitable human-derived cell types for many biomedical, 
biophysical andpharmaceutical research in the near future.  
 
With technology improving in all facets in the field of science, it will be only a matter of 
time for us to fully understand the effect of tau on microtubule structure and molecular motor 
transport from molecular mechanism, to collective function and larger scale cellular impacts.  
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